Emmett T. Cunningham, Jr, MD, PhD, MPH

Dr. Cunningham sees patients in the following West Coast Retina location:

Curriculum Vitae

Work Address
West Coast Retina Medical Group
1445 Bush Street
San Francisco, CA 94109

Education

Post Doctoral Training

Research Fellowships

Licensure and Board Certification

Academic & Administrative Appointments

Hospital Appointments

Memberships, Offices and Committee Appointments

Awards & Honors
Faculty:

Fellowship: Residency: Internship: Graduate School: Medical School:

Editorial Boards

Research Interests

Bibliography

Refereed Publications
  1. Ciuffo, AA, Cunningham ET Jr, Traille TA. Familial pulmonary valve stenosis, atrial septal defect, and unique electrocardiogram abnormalities. J Med Gent 1985; 22:311-313.
  2. Cunningham ET Jr, LeVay S. Laminar and synaptic organization of the projection from the thalamic nucleus centralis to primary visual cortex in the cat. J Comp Neurol 1986; 254:65-77.
  3. Cunningham ET Jr, Sawchenko PE. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol 1987; 274:60-70.
  4. Sawchenko PE, Plotsky PM, Pfeiffer SW, Cunningham ET Jr, Vaughn J, Rivier J, Vale W. Inhibin b-immunoreactivity in a visceral sensory system controlling oxytocin secretion in rat brain. Nature 1987; 334:6183-6185.
  5. Cunningham ET Jr, Sawchenko PE. A circumscribed projection from the nucleus of the solitary tract to the nucleus ambiguus in the rat: anatomical evidence for somatostatin-28 immunoreactive interneurons subserving reflex control of esophageal motility. J Neurosci 1989; 9(5):1668-1682.
  6. Plotsky PM, Cunningham ET Jr, Widmaier EP. Catecholaminergic Modulation of Corticotropin-Releasing Factor and Adrenocorticotropin Secretion. Endocrine Rev 1989; 10(4):437-458.
  7. Cunningham ET Jr, Roberts VJ, Bittencourt JC, Plotsky PM, Vale W, Sawchenko, PE. Medullary cell groups providing differential control of magnocellular oxytocin and vasopressin neurons in the rat. J Neuroendocrinology 1990; 2 (Suppl):53-55.
  8. Cunningham ET Jr, Bohn MC, Sawchenko PE. The organization of adrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol 1990; 292:651-667.
  9. Cunningham ET Jr, Sawchenko PE. Central neural control of esophageal motility: A review. Dysphagia 1990; 5(1):35-51.
  10. Cunningham ET Jr, Simmons DM, Swanson LW, Sawchenko PE. Enkephalin-immunoreactivity and messenger RNA in a discrete projection from the nucleus of the solitary tract to the nucleus ambiguus in the rat. J Comp Neurol 1991; 307:1-16.
  11. Cunningham ET Jr, Wada E, Carter DB, Tracey DE, Battey JF, De Souza EB. Localization of interleukin-1 receptor messenger RNA in murine hippocampus. Endocrinology 1991; 128(5):2666-2668.
  12. Labandeira-Garcia JL, Wictorin K,Cunningham ET Jr, Bjorklund A. Development of the host afferent innervation of intrastriatal striatal grafts. Neuroscience, 1991; 42(2):407-426.
  13. Cunningham ET Jr, Sawchenko PE. Reflex control of magnocellular vasopressin and oxytocin secretion. Trends Neurosci 1991; 14(8):406-411.
  14. Eliott D, Cunningham ET Jr, Miller NR. Fourth nerve paresis and ipsilateral relative afferent pupillary defect without visual sensory disturbance: A sign of contralateral dorsal midbrain disease. J Clin Neuro-ophthal 1991; 11(3):169-172.
  15. Cunningham ET Jr, Wada E, Carter DB , Tracey DE, Battey JF, De Souza EB. In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse. J Neurosci 1992; 12(3):1101-1114.
  16. Cunningham ET Jr, Ravich WJ, Jones B, Donner MW. Vagal reflexes referred from the upper aerodigestive tract: An infrequently recognized cause of common cardiorespiratory responses. Ann Int Med 1991; 116:575-582.
  17. Cunningham ET Jr, Wada E, Carter DB, Tracey DE, Battey JF, De Souza EB. Distribution of type I interleukin-1 receptor messenger RNA in testis: An in situ histochemical study in the mouse. Neuroendocrinology 1992; 56:94-99.
  18. Cunningham ET Jr, De Souza EB. Interleukin-1 receptors in brain and endocrine tissues. Immunology Today 1993; 14(4):171-176.
  19. Cunningham ET Jr, Miselis RR, Sawchenko PE. The relationship of efferent projections from the area postrema to vagal motor and brain stem catecholamine-containing cell groups: An axonal transport and immunohistochemical study in the rat. Neuroscience 1993; 58(3):635-648.
  20. Cunningham ET Jr, Good WV. Isolated inferior branch oculomotor nerve paresis: A case report. J Clin Neuro-ophthalmol 1994; 14(1):21-23.
  21. Holtzman DM, Kilbridge J, Yiwen L, Cunningham ET Jr, Lenn NJ, Clary DO, Reichardt LF, Mobley WC. TrkA expression in the CNS: Evidence for the existence of several novel NGF-responsive CNS neurons. J Neurosci 1994; 15(2):1567-1576.
  22. Cunningham ET Jr, Demetrius R, Frieden IJ, Emery HM, Irvine AR, Good WV. Vogt-Koyanagi-Harada syndrome in a 4-year-old child. Am J Ophthalmol 1995; 120(5):675-677.
  23. Cunningham ET Jr, Irvine AR, Rugo HS. Bone marrow transplantation retinopathy in the absence of radiation therapy. Am J Ophthalmol 1996; 122:268-270.
  24. Cunningham ET Jr, Short GA, Irvine AR, Duker JS, Margolis TP. AIDS-associated herpes simplex virus retinitis: Clinical description and use of a polymerase chain reaction-based assay as a diagnostic tool. Arch Ophthalmol 1996; 114:834-840.
  25. Cunningham ET Jr, Alfred PR, Irvine AR. Central serous chorioretinopathy in patients with systemic lupus erythematosus. Ophthalmology 1996; 103:2081-2090.
  26. Cunningham ET Jr, Schatz H, McDonald HR, Johnson RN. Acute multifocal retinitis. Am J Ophthalmol 1997; 123:347-357.
  27. Cunningham ET Jr, Sanna PP, Liu SS, Bloom FE, Howes EL Jr, Margolis TP. Localization of tumor necrosis factor receptor messenger RNA in normal and herpes simplex virus infected mouse eyes. Invest Ophthalmol Vis Sci 1997; 38:9-15.
  28. Cunningham ET Jr, Stalder A, Sanna PP, Liu SS, Bloom FE, Howes EL Jr, Campbell I, Margolis TP. Distribution of tumor necrosis factor receptor mRNA in normal and herpes simplex virus infected trigeminal ganglia in the mouse. Brain Res 1997; 758:99-106.
  29. Rathinam S, Namperumalsamy P, Nozik RA, Cunningham ET Jr. Angle closure glaucoma as a presenting sign of Vogt Koyanagi Harada syndrome. Br J Ophthalmol 1997; 81:608-609.
  30. Jones MR, Cunningham ET Jr. Bartonella henselae-associated acute multifocal retinitis in a patient with the acquired immune deficiency syndrome. Retina 1997; 17:457-459.
  31. Cunningham ET Jr. New treatments for CMV retinitis in patients with AIDS. West J Med 1997; 166:138-139.
  32. Cunningham ET Jr, McDonald HR, Grand MG, Schatz H, Johnson RN, Ai E. Inflammatory mass of the optic nerve head associated with systemic Bartonella henselae infection. Arch Ophthalmol 1997; 115:1596-1597.
  33. Silverstein BE, Cunningham ET Jr, Margolis TP, Cevallos V, Wong IG. Microsporidial keratoconjunctivitis in a patient without human immunodeficiency virus infection. Am J Ophthalmol 1997; 124:395-396.
  34. Cunningham ET Jr, Nozik RA. Case Discussion: Purtscher’s retinopathy. In: Diagnostic and Therapeutic Challenges. Retina, 1997; 17:444-448.
  35. Silverstein BE, Smith JH, Sykes SO, Jones MR, Schwartz D, Cunningham ET Jr. Cystoid macular edema associated with cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 1998; 125:411-415.
  36. Cunningham ET Jr, Eliott D, Miller NR, Maumenee IH, Green WR. Familial Axenfeld-Rieger anomaly, atrial septal defect, and sensorineural hearing loss - a possible new genetic syndrome. Arch Ophthalmol 1998; 116:78-82.
  37. Thygeson P, O'Connor GR, Dawson CR, Whitcher JP, Cunningham, ET Jr. The Francis I. Proctor Foundation: The First 50 years. Surv Ophthalmol 1998; 42:548-556.
  38. Cunningham ET Jr, Margolis TP. Ocular manifestations of HIV infection. N Engl J Med 1998; 339:236-244.
  39. Duncan JL, Golabi M, Fredrick DR, Hoyt CS, Hwang DG, Kramer SG, Howes EL Jr, Cunningham ET Jr. Complex limbal choristomas in linear nevus sebaceous syndrome. Ophthalmology 1998; 105:1459-1465.
  40. Cubillan L, Cubillan E, Berger TG, Seiff SR, Crawford JB, Howes EL Jr, Cunningham ET Jr. Syphilitic uveitis and dermatitis. Arch Ophthalmol 1998; 116:696-697.
  41. Cunningham ET Jr, Seiff SR, Berger TG, Lizotte PE, Howes EL Jr, Horton JC. Intraocular coccidioidomycosis diagnosed by skin biopsy. Arch Ophthalmol 1998; 116:674-677.
  42. Grewal A, Kim RY, Cunningham ET Jr. Miliary tuberculosis. Arch Ophthalmol 1998; 116:953-954.
  43. Geleziunas R, Ferrell S, Lin X, Mu Y, Cunningham ET Jr, Connelly MA, Marcu KB, Greene WC. HTLV-I tax induction of NF-kB involves activation of the IKKa/CHUK cellular kinase. Mol Cell Biol 1998; 18:5157-5165.
  44. Lin X, Mu Y, Cunningham ET Jr, Marcu KB, Geleziunas R, Greene WC. Molecular determinants of NF-kB inducing kinase (NIK) action. Mol Cell Biol 1998; 18:5899-5907.
  45. Rathinam S, Vijayalakshmi P, Namperumalsamy P, Nozik RA, Cunningham ET Jr. Vogt Koyanagi Harada syndrome in children. Ocular Immunology and Inflammation 1998; 6:155-161.
  46. Whitcup SM, Cunningham ET Jr, Polis MA, Fortin E. Spontaneous and sustained resolution of CMV retinitis in patients receiving highly active antiretroviral therapy. Br J Ophthalmol 1998; 82:845-846
  47. Rimpel NR, Cunningham ET Jr, Howes EL Jr, Kim RY. Viridans group Streptococcus subretinal abscess. Br J Ophthalmol 1999; 83:373-374.
  48. Rathinam S, Namperumalsamy SP, Nozik RA, Cunningham ET Jr. Vogt Koyanagi Harada syndrome following cutaneous injury. Ophthalmology 1999; 106:635-638.
  49. Sykes SO, Riemann C, Santos CI, Meisler DM, Lowder CY, Whitcher JP, Cunningham ET Jr. Haemophilus Influenzae-Associated Necrotizing Scleritis. Br J Ophthalmol 1999; 83:410-413.
  50. Zegans ME, Srinivasan M, Santhi CB, McHugh T, Whitcher JP, Margolis TP, Lietman T, Jennette JC, Cunningham ET Jr. Mooren ulcer in South India: Serology and clinical risk factors. Am J Ophthalmol 1999; 128:205-210.
  51. Lin X, Cunningham ET Jr, Mu Y, Geleziunas R, Greene WC. The Cot/Tpl-2 proto-oncogene kinase participates in CD3/CD28 signaling promoting IkB kinase (IKK) activation and induction of NF-kB. Immunity 1999; 10:271-280. (Dr. Lin and Dr. Cunningham were co-first authors).
  52. Wade NK, Po S, Wong IG, Cunningham ET Jr. Bilateral Bartonella-associated neuroretinitis. Retina 1999; 19:355-356.
  53. Cunningham ET Jr. Case Discussion: Bartonella-henselae-associated retinitis. In: Diagnostic and Therapeutic Challenges. Retina 1999; 19:558-562.
  54. Cunningham ET Jr, Sawchenko PE. Dorsal medullary pathways subserving oromotor reflex function in the rat: Implications for the central neural control of swallowing. J Comp Neurol 2000; 417:448-466.
  55. Stechschulte SU, Kim RY, Cunningham ET Jr. Tuberculous neuroretinitis. J. Neuro-ophthalmol 1999; 19:201-204.
  56. Taylor CJ, Smith SI, Morgan CH, Stephenson SF, Key T, Srinivasan M, Cunningham ET Jr, Watson PG. HLA and Mooren’s Ulceration. Br J Ophthalmol 2000; 84:72-75.
  57. Jacobson MA, Stanley H, Holtzer C, Margolis TP, Cunningham ET Jr. Natural history and outcome of new AIDS-related cytomegalovirus (CMV) retinitis cases diagnosed in the era of highly active antiretroviral therapy: Implications for optimal anti-CMV treatment strategies. Clinical Infectious Diseases 2000; 30:231-233.
  58. Kuo IC, Rechdouni A, Rao NA, Johnston RH, Margolis TP, Cunningham ET Jr. Subretinal fibrosis in patients with Vogt-Koyanagi-Harada disease. Ophthalmology, 2000; 107(9):1721-1728.
  59. Rathinam SR, Namperumalsamy P, Cunningham ET Jr. Spontaneous cataract absorption in patients with leptospiral uveitis. Br J Ophthalmol 2000; 84:1135-1141.
  60. Ramsay A, Cunningham ET Jr, Pavesio C. Acute retinal necrosis presenting with scleritis and raised intraocular pressure. Br J Ophthlamol 2000; 84:1208-1209.
  61. Gaynor BD, Stamper RL, Cunningham ET Jr. Presumed activation of herpetic keratouveitis following argon laser peripheral iridotomy. Am J Ophthlalmol 2000; 130(5):665-667.
  62. Cunningham ET Jr, Koehler, JE. Ocular bartonellosis. Am J Ophthalmol 2000; 130:340-349.
  63. Wade NK, Levi L, Jones MR, Bhisitkul R, Fine L, Cunningham ET Jr. Optic disc edema associated with peripapillary serous retinal detachment: An early sign of systemic Bartonella henselae infection. Am J Ophthalmol 2000; 130:327-334.
  64. Cunningham ET Jr. Uveitis in HIV-positive patients. Br J Ophthalmol 2000; 84:233-237.
  65. Cunningham ET Jr. Case Discussion: Optic disc swelling, serous macular detachment, and a macular star in a patient with a congenital pre-papillary venous loop. In: Diagnostic and Therapeutic Challenges. Retina 2001; 20(5):541-54.
  66. Sanislo SR, Lowder CY, Kaiser PK, Gutman FA, Zegarra H, Dodds EM, Dailey JP, Meisler DM, Cunningham ET Jr. Corticosteroid therapy for optic disc neovascularization secondary to chronic uveitis. Am J Ophthlamol 2001; 130(6):724-731.
  67. Kuo IC, Fan J, Cunningham ET Jr. Ophthalmic manifestations of neonatal onset multisystem inflammatory disease. Am J Ophthlamol 2001; 130(6):856-858.
  68. Fawzi AA, Cunningham ET Jr. Central serous chorioretinopathy following bone marrow transplantation. Am J Ophthalmol 2001; 131:804-805.
  69. Solomon SD, Cunningham ET Jr. Use of corticosteroids and noncorticosteroid immunosuppressive agents in patients with uveitis. Comprehensive Ophthalmology Update 2001; 1(5):273-286.
  70. Cunningham ET Jr. Diagnosing and treating herpetic anterior uveitis (Editorial). Ophthalmology 2001; 107(12):2129-2130.
  71. Cunningham ET Jr, Sabrosa NA, Pavesio CE. Posterior scleritis mimicking birdshot retinochoroidopathy. Eye 2001; 15(2):231-233.
  72. Gaynor BD, Wade NK, Cunningham ET Jr. Herpes simplex virus type 1 associated acute retinal necrosis six years after encephalitis. Retina 2001; 21:688-690.
  73. Chang MS, Lee SS, Cunningham ET Jr. Focal retinal phlebitis as a presenting sign of systemic Bartonella henselae infection. Retina 2001; 21(3):280-281.
  74. Tham VM-B, Cunningham ET Jr. Anterior ischemic optic neuropathy in a patient with HLA-B27-associated anterior uveitis and ankylosing spondylitis. Br. J. Ophthalmol 2001; 85(6):756.
  75. Kestelyn PG, Cunningham ET Jr. HIV/AIDS and Global Blindness. Bulletin of the World Health Organization 2001; 79(3):208-213.
  76. Cunningham ET Jr, Levinson RD, Jampol LM, Engstrom RE Jr, Lewis H, Holland GN. Ischemic maculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 2001; 132:727-733.
  77. Alrawi A, Chern KC, Cevallos V, Lietman T, Whitcher JP, Margolis TP, Cunningham ET Jr. Biotypes and serotypes of Haemophilus influenzae ocular isolates. Br J Ophthalmol 2002; 86:276-277.
  78. Fine L, Fine A, Cunningham ET Jr. Multiple evanescent white dot syndrome following hepatitis A vaccination. Arch. Ophthlamol 2001; 119:1856-1858.
  79. Bui SK, O’Brien JM, Cunningham ET Jr. Purtscher’s retinopathy following drug-induced pancreatitis in an HIV-positive patient. Retina 2001; 21(5):542-545.
  80. Cunningham ET Jr. Uveitis in Children. Ocular Immunology and Inflammation 2001; 8(4):251-261.
  81. Cunningham ET Jr, Rathinam SR. TB or not TB? The perennial question (Editorial). Br J Ophthalmol 2001; 85:127-129.
  82. Cunningham ET Jr. World blindness – no end in sight. (Editorial). Br J Ophthalmol 2001; 85:253.
  83. Cunningham ET Jr, Lietman T, Whitcher JP. Blindness: A global priority for the 21st century. Bulletin of the World Health Organization 2001; 79(3):180.
  84. Cunningham ET Jr. Diagnosis and management of acute anterior uveitis. American Academy of Ophthalmology, Focal Points 2002, Volume XX, number 1 (Section 1 of 3).
  85. Borodoker N, Cunningham ET Jr, Yannuzzi L, Nicoletti R. Peripheral curvilinear pigmentary streak in multifocal choroiditis. Arch Ophthalmol 2002; 120(4):520-521.
  86. Chipont BE, Cunningham ET Jr. Manejo del paciente con uveitis anterior aguda. Arch Soc Esp Oftalmol 2002; 77:183-194.
  87. Cunningham ET Jr, da Silva L, Harrison EM, Modi MW, O’Shaughnessy D, Guyer DR. Accelerated drug development through combined phase 2/3 clinical trial design. Arch Ophthalmol 2004; 122:1043-1044.
  88. Shukla D, Mohan KC, Rao N, Kim R, Namperumalsamy P, Cunningham ET Jr. Posterior scleritis causing combined central retinal artery and vein occlusion. Retina 2004; 24:467-469.
  89. Vendantham V, Kim R, Namperumalsamy P, Cunningham ET Jr. Double prepapillary arterial loops associated with superior branch macular artery occlusion. Ind J Ophthalmol 2004 53(2):126-128.
  90. Varaprasathan G, Miller K, Lietman T, Whitcher JP, Cevallos V, Okumoto M, Margolis TP, Yinghui M, Cunningham ET Jr. Trends in the etiology of corneal ulcers at the F.I. Proctor Foundation. Cornea 2004; 23(4):360-364.
  91. Shukla D, Mohan KC, Rao N, Kim R, Namperumalsamy P, Cunningham ET Jr. Posterior scleritis causing combined central retinal artery and vein occlusion. Retina 2004; 24(3):467-469.
  92. Jager RD, Aiello LP, Patel SC, Cunningham ET Jr. Risks of intravitreous injection: A comprehensive review. Retina 2004; 24:676-698.
  93. Aiello LP, Brucker AJ, Chang S, Cunningham ET Jr, D’Amico DJ, Flynn HW, Grillone LR, Hutcherson S, Liebmann, JM, O’Brien TP, Scott IU, Spaide R, Ta C, Trese M. Evolving guidelines for intravitreous injections. Retina 2004; 24:S3-S19.
  94. Stewart JM, Cubillan LDP, Cunningham ET Jr. Prevalence, clinical features, and causes of vision loss in patients with ocular toxocariasis. Retina 2005, 25:1005-1013.
  95. Burton BJL, Cunningham ET Jr, Cree IA, Pavesio CE. Eye involvement mimicking scleritis in a patient with chronic lymphocytic leukemia. Br J Ophthalmol 2005, 89:775-776.
  96. Gragoudas ES, Adamis T, Cunningham ET Jr, Guyer RD, Feinsod M for The VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004, 351:2805-2816.
  97. The Macugen Diabetic Retinopathy Study Group. A phase II randomized, double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 2005; 112:1747-1757.
  98. The VEGF Inhibition Study in Ocular Neovascularization (VISION) Clinical Trial Group. Enhanced efficacy associated with early treatment of neovascular age-related degeneration with pegaptanib sodium: An exploratory analysis. Retina 2005, 25:815-827.
  99. Fawzi AA, Holland GN, Kreiger AE, Heckenlively JR, Arroyo J, Cunningham ET Jr. Central serous chorioretinopathy following solid organ transplantation. Ophthalmology 2006, 113:805-813.
  100. Shukla D, Namperumalsamy P, Goldbaum M, Cunningham ET Jr. Pegaptanib sodium for ocular vascular disease. Indian J Ophthalmol 2007; 55(6):427-430.
  101. Roe R, Branco BC, Cunningham ET Jr. Hypotony maculopathy in a patient with HLA-B27-associated uveitis. Ocul Immunol Inflamm 2008, 16(3):107-108.
  102. Krishnamurthy R, Cunningham ET Jr. Atypical presentation of syphilitic uveitis associated with Kyrieleis plaques. Br J Ophthalmol 2008, 92(8):1152-1153.
  103. Adamis AP, Altaweel M, Bressler NM, Cunningham ET Jr, Davis MD, Goldbaum M, Gonzales C, Guyer DR, Barrett K, Patel M; Macugen Diabetic Retinopathy Study Group. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals. Ophthlamology 2006: 113(1):23-28.
  104. Pegaptanib sodium for neovascular age-related macular degeneration: Two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmol 2006, 113:992-1001.
  105. Ng EWM, Shima DT, Calias P, Cunningham ET Jr, Guyer Dr, Adamis AP. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Disc 2006, 5:123-132.
  106. VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group; Chakravarthy U, Adamis AP, Cunningham ET Jr, Goldbaum M, Guyer DR, Katz B, Patel M. Ophthalmol 2006, 113(9):1508.e1-25.
  107. Reddy S, Cunningham, ET Jr, Spaide RK. Syphilitic retinitis with focal inflammatory accumulations. Ophthalmic Surg, Lasers, Imag 2006, 37:429-431.
  108. Reddy S, Roe R, Cunningham ET Jr, Flaxel C, Emerson G, Ober M. Diagnostic and Therapeutic Challenges 2006, 26(8):954-959.
  109. VEGF inhibition study in ocular neovascularization (V.I.S.I.O.N.) clinical trial group, Chakravarthy U, Adamis AP, Cunningham ET Jr, Goldbaum M, Guyer DR, Katz B. Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology 2006; 113(9); 1508. e1-25
  110. VEGF inhibition study in ocular neovascularization (V.I.S.I.O.N.) clinical trial group, D’Amico DJ, Masonson HN, Patel M, Adamis AP, Cunningham ET Jr, Guyer DR, Katz B. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 2006; 113(6):992-1001.
  111. Zelefsky JR, Srinivasan M, Kundu A, Lietman T, Whitcher JP, Wang K, Buyse M, Cunningham ET Jr. Hookworm infestation as a risk factor for Mooren’s ulcer in South India. Ophthalmology 2007, 114(3):450-453.
  112. Srinivasan M, Zegans ME, Zelefsky JR, Kundu A, Leitman T, Whitcher JP, Cunningham ET Jr. Clinical characteristics of Mooren’s ulcer in South India. Br J Ophthalmol 2007, 91(5):570-575.
  113. Reddy S, Cubillan LDP, Chiu C, Hovakimyan A, Cunningham ET Jr. Inflammatory ocular hypertension syndrome (IOHS) in patients with syphilitic uveitis. Br J Ophthalmol, 2007: 91(12):1610-1612.
  114. Roe R, Fisher Y, Eagle R, Skinner M, Cunningham ET Jr. Oculoleptomeningeal amyloidosis in a patient with a TTR-glycine 30 mutation in the transthyretin gene. Ophthalmology 2007, 114:e33-e37.
  115. Shukla D, Namperumalsamy P, Goldbaum M, Cunningham ET Jr. Pegaptanib sodium for ocular vascular disease. Indian J Ophthalmol 2007, 55(6):427-430.
  116. Cunningham ET Jr, Adamis AP, Goldbaum M. Pegaptanib sodium for the treatment of ocular vascular disease. Expert Opin Ophthlamol 2007: 2(1):45-60.
  117. Shein, J, Shukla D, Reddy S, Yannuzzi LA, Cunningham ET Jr. Macular infarction as a presenting sign of systemic lupus erythematosus. Retina Cases & Case Series 2008, 2:55-60.
  118. Acharya N, Srinivasan M, Kundu A, Leitman T, Whitcher JP, Cunningham ET Jr. Mooren’s ulcer following cataract surgery. Euro J Ophthalmol 2008, 18(3):351-355.
  119. Wender JD, Fu AD, Jumper JM, McDonald HR, Johnson RN, Cunningham ET Jr. False negative antibody-based HLA-A29 typing in patients with birdshot chorioretinopathy. Br J Ophthalmol, 2008: 92(8):1153-1154.
  120. Zelefsky JR, Lietman T, Whitcher JP, Cunningham ET Jr, Srinivasan M. Author reply. Ophthalmol 2008: 115(1):224.
  121. London NJS, Belfort R Jr, Cunningham ET Jr. ICO Treatment Guidelines, Ocular HIV/AIDS related diseases. 2009, http://www.icoph.org/pdf/ICOHIVAIDS.pdf.
  122. Dodds EM, Holland GN, Stanford MR, Yu F, Siu WO, Shah KH, ten Dam-van Loon N, Muccioli C, Hovakimyan A, Barisani-Asenbauer T, and the International Ocular Toxoplasmosis Research Group. Intraocular inflammation associated with ocular toxoplasmosis: Relationships at initial examination. Am J Ophthalmol, 2008, 146(6):856-865.e2.
  123. Singerman LJ, Masonson H, Patel M, Adamis AP, Buggage R, Cunningham ET Jr, Goldbaum M, Katz B, and Guyer DR. Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial.. Br J Ophthalmol 2008, 115(9):1447-1449, 1449.e1-10.
  124. Accorinti M, Cunningham ET Jr. Bartonellosi Oculare. Bollettino di Oculistica 2008; 87(1):17-22.
  125. Pomerleau D, Roe RH, McDonald HR, Johnson RN, Ai E, Jumper MJ, Fu AD, Cunningham ET Jr, Wong RW. Angiod streaks and optic nerve head drusen in hyperphosphatemic familial tumor calcinosis. Retinal Cases & Brief Reports 2009; 3:54-56.
  126. Cunningham ET Jr., Suhler EB. Childhood uveitis – young patients, old problems, new perspectives. J AAPOS, 2008, 12(6):537-538.
  127. Ng EW, Shima DT, Callas P, Cunningham ET Jr, Guyer DR, Adamis AP. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov 2006; 5(2):123-132.
  128. Zelefsky JR, Taylor CJ, Srinivasan M, Peacock S, Goodman RS, Key T, Watson PG, Cunningham ET Jr. HLA-DR17 and Mooren's ulcer in South India. Br J Ophthalmol 2008; 92(2):179-81.
  129. Wroblewski, JJ, Wells JA III, MD, Adamis AP, Buggage RR, Cunningham ET Jr, Goldbaum M, Guyer DR, Katz B, Altaweel MM, for the Pegaptanib in Central Retinal Vein Occlusion Study Group. Pegaptanib Sodium for Macular Edema Secondary to Central Retinal Vein Occlusion. Arch Ophthalmol 2009: 127(4):374-80.
  130. Fine HF, Cunningham ET Jr, Kim E, Smith T, Chang S. Autofluorescence findings in longstanding chorioretinal folds. Retina Cases & Case Series 2009; 3:137-139.
  131. Wender JD, Johnson RN, Roe RH, Bui AT, Fu AD, Jumper JM, Cunningham ET Jr, McDonald HR. Resolution of a giant pigment epithelial detachment after treatment with intravitreal bevacizumab. Retinal Cases & Brief Reports, 2009; 3:130-132.
  132. Cunningham ET Jr, London NJS, Rathinam SR. Uveitis: A global view. Expert Rev Ophthalmol 2010; 5(3):113-114.
  133. Wong RW, Mcdonald HR, Jumper JM, Fu AD, Johnson RN, Ai E, Cunningham ET Jr. Surgically induced necrotizing scleritis and optic neuropathy following pars plana vitrectomy as presenting signs of Churg-Strauss syndrome. Retina Cases & Case Series 2009; 3:398-399.
  134. Cunningham ET Jr, Baglivo E. Fuchs heterochromic iridocyclitis--syndrome, disease, or both? Am J Ophthalmol 2009; 148(4):479-81.
  135. London NJS, Wong RW, Roe RH, Jumper JM, Fu A, Johnson RN, Ai E, Cunningham ET Jr, McDonald RM. Obliterative Idiopathic Juxtafoveal Telangiectasis: A 25-Year Follow-up. Retinal Cases & Brief Reports, 2010; 4:86-90.
  136. Zelefky JR, Cunningham ET Jr. Evaluation and Management of Elevated IOP in Patients with Uveitis. American Academy of Ophthalmology. June, 2010; Focal Points, Volume XXVIII, Number 6, Module 3 of 3.
  137. Roe RH, Rathinam SR, Wong RW, McDonald HR, Jumper JM, Cunningham ET Jr. Delayed fellow eye involvement in patients with Vogt Koyanagi Harada disease. Br J Ophthalmol, 2009, 93:701-702.
  138. Jumper JM, Pomerleau D, McDonald HR, Johnson RN, Fu AD, Cunningham ET Jr. Macular fibrosis in Coats disease. Retina 2010; 30(4 Suppl):S9-14.
  139. Lima LH, Shakin E, Sen HN, Nussenblatt RB, Yannuzzi LA, Jampol LM, Cunningham ET Jr. Diagnostic and therapeutic challenges. Retina 2010; 30(4):700-4.
  140. Roe RH, Cunningham ET Jr. Considering amyloidosis in patients with clinically unresponsive vitreous inflammation (Oculoleptomeningeal amyloidosis in 3 individuals with transthyretin variant Tyr69His. Vol. 44[3]). Can J Ophthalmol 2010;45(1):81.
  141. Martin TD, Rathinam SR, Cunningham ET Jr. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India. Retina 2010; 30(7):1113-21.
  142. Cunningham ET Jr. Exogenous factors influencing endogenous inflammation: what can patients do to improve control of their own uveitis? Br J Ophthalmol 2010; 94(7):813-4.
  143. Doshi RR, Arevalo JF, Flynn HW Jr, Cunningham ET Jr. Evaluating Exaggerated, Prolonged, or Delayed Postoperative Intraocular Inflammation. Am J Ophthalmol 2010 Jul 12. [Epub ahead of print]
  144. Wong RW, Chan A, Johnson RN, McDonald HR, Kumar A, Gariano R, Cunningham ET Jr. Posterior scleritis in patients with systemic lupus erythematosus. Retinal Cases & Brief Reports, 2010, In press.
  145. London NS, Siverio C Jr, Cunningham ET Jr. Conjunctival lymphoma following treatment with cyclophosphamide. Eye 2010; 24(7):1294-5.
  146. Fu EX, Geraets RL, Dodds EM, Echandi LV, Colombero D, McDonald HR, Jumper JM, Cunningham ET Jr. Superficial retinal precipitates in patients with syphilitic retinitis. Retina. 2010;30(7):1135-43.
  147. Roe RH, McDonald HR, Fu AD, Lahey JM, Wendel RT, Pearlman JA, Monahan PM, Jumper JM, Johnson RN, Ai E, Cunningham ET Jr. Unexplained vision loss following removal of epiretinal membrane. Br J Ophthalmol 2010 Jun 24. [Epub ahead of print].
  148. Cunningham ET Jr, Wender JD. A practical approach to the use of corticosteroids in patients with uveitis. Can J Ophthalmol 2010; In press.
  149. Rathinam SR, Cunningham ET Jr. Spontaneous hypheama and acute ocular hypertension associated with severe lens-induced uveitis. Eye 2010; In press.
  150. Rathinam SR, Cunningham ET Jr. Vitiligo iridis in patients with a history of smallpox infection. Eye 2010; In press.
  151. Wong R, Chan A, Johnson RN, McDonald HR, Kumar A, Gariano R, Cunningham ET. Posterior Scleritis in Patients with Systemic Lupus Erythematosus. Retinal Cases and Brief Reports 2010;4(4):326-31.
  152. Roe RH, Jumper JM, Gualino V, Wender J, McDonald HR, Johnson RN, Fu AD, Cunningham ET Jr. Retinal pigment epitheliopathy, macular telangiectasis, and intraretinal crystal depostis in HIV-positive patients receiving ritonavir. Retina 2010; Oct 20. [Epub ahead of print].
  153. Rathinam SR, Cunningham ET Jr. Vitiligo iridis in patients with a history of smallpox infection. Eye 2010; 24(10):1621-2. Epub 2010 Aug 20.
  154. Cunningham ET Jr, Zeirhut M. TNF inhibitors in uveitis: Balancing efficacy and safety. Ocul Immunol Inflamm 2010; 18(6):421-3.
  155. Wakefield D, Cunningham ET Jr, Pavesio C, Garweg JG, Zierhut M. Controversies in ocular toxoplasmosis. Ocul Immunol Inflamm 2011; 19(1):2-9.
  156. Del Piero EJ, Cunningham ET Jr, Sabrosa N, Khairallah M, Kahloun R. Diagnostic and therapeutic challenges. Retina 2011; 31(7):1428-34.
  157. Sultan MB, Zhou D, Loftus J, Dombi T, Ice KS; Macugen 1013 Study Group. A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema. Ophthalmology 2011; 118(6):1107-1118. Epub 2011 May 6.
  158. London NJS, Hovakimyan A, Cubillan LDP, Siverio CD, Cunningham ET Jr. Prevalence, clinical characteristics, and causes of vision loss in patients with ocular toxoplasmosis. Eur J Ophthalmol 2011; 21(6):811-9. doi: 10.5301/EJO.2011.6403.
  159. Hoang QV, Freund KB, Klancnik JM Jr, Sorenson JA, Cunningham ET Jr, Yannuzzi LA. Focal retinal phlebitis. Retina 2012; 32(1):120-126.
  160. Cunningham ET Jr, Feiner L, Chung C, Tuomi L, Ehrlich JS. Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration. Ophthalmology 2011; 118(12):2447-2452.
  161. Cunningham ET Jr, Hubbard LD, Danis RP, Holland GN. Proportionate topographic areas of retinal zones 1,2, and 3 for use in describing infectious retinitis. Arch Ophthalmol 2011; 129(11):1507-1508.
  162. Wender JD, Johnson RN, McDonald HR, Jumper JM, Fu AD, Lujan B, Cunningham ET Jr. Continued vision loss from progressive expansion of inactive chorioretinal scars in a myopic patient with well controlled sympathetic ophthalmia. Retinal Cases & Brief Reports, epub December 5, 2011; DOI Number: 10.1097/ICB.0b013e31823f09bb
  163. Wender JD, Rathinam SR, Shaw RE, Cunningham ET Jr. Intraocular cysticercosis: Case series and comprehensive review of the literature. Ocul Immunol Inflamm 2011S; 19(4):240-245.
  164. Loftus JV, Sultan MB, Pleil AM; Macugen 1013 Study Group. Changes in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham. Invest Ophthalmol Vis Sci 2011; 52(10):7498-7505.
  165. Zelefsky JR, Srinivasan M, Cunningham ET Jr. Mooren’s Ulcer. Exp Rev Ophthalmol 2011, 6(4): 461-467.
  166. Cunningham ET Jr. Cytomegalovirus – ophthalmic perspectives on a pervasive pathogen. Expert Rev Ophthalmol 2011; 6(5):489-491.
  167. Cunningham ET Jr. The expanding spectrum of viral anterior uveitis. Ophthalmology 2011; 118(10):1903-4.
  168. Jumper JM, McDonald HR, Johnson RN, Fu AD, Cunningham ET Jr. Macular fibrosis in Coats disease (Reply). Retina 2011; 31(10):2137-8.
  169. Roe RH, Jumper JM, Gualino V, Wender J, McDonald HR, Johnson RN, Fu AD, Cunningham ET Jr. Retinal pigment epitheliopathy, macular telangiectasis, and intraretinal crystal depostis in HIV-positive patients receiving ritonavir (reply) Retina 2012; 32(2):412
  170. Davis EJ, Rathinam SR, Okada AA, Tow SL, Graham EM, Petrushkin H, Chee SP, Guex-Crosier Y, Mackensen F, Tugal-Tutkun I, Cunningham ET Jr, Leavitt JA, Mansour AM, Winthrop KL, Hills WL, Smith JR. Clinical spectrum of tuberculous optic neuropathy. J Ophthalmic Inflamm Infect 2012; 2012 Dec;2(4):183-9.
  171. Cunningham ET Jr, Pasadhika S, Suhler EB, Zierhut M. Drug-induced inflammation in patients on TNF inhibitors. Ocul Immunol Inflamm 2012; 20(1):2-5.
  172. Cunningham ET Jr, Goldstein DA, Zierhut M. Uveitis treatment trials – A cross trial perspectives. Ocul Immunol Inflamm 2012; 20(2):63-67.
  173. Cunningham ET Jr. Surveying uveitis specialists – A call for consensus. J Ophthalmic Inflamm Infect 2012; 2(2):61-3. Epub 2012 Mar 28.
  174. Wender JD, Rathinam SR, Shaw RE, Cunningham ET Jr. Author response to "Intraocular Cysticercosis" by Somsri Wiwanitkit and Viroj Wiwanitkit. Ocul Immunol Inflamm 2012; 20(2):148.
  175. Jhaveri CD, Jampol LM, Van Gelder RN, Cunningham ET Jr. Diagnostic and Therapeutic Challenges. Retina 2012, 32(5):1028-32.
  176. Wakefield D, Cunningham ET Jr, Tugal-Tutkun I, Khairallah M, Ohno S, Zierhut M. Controversies in behçet disease. Ocul Immunol Inflamm 2012; 20(1):6-11.
  177. Eandi CM, Neri P, Adelman RA, Yannuzzi LA, Cunningham ET Jr, on behalf of the international syphilis study group. Acute syphilitic posterior placoid chorioretinitis: Report of a case series and comprehensive review of the literature. Retina 2012; 2012 Oct;32(9):1915-41.
  178. Wong RW, Jumper JM, McDonald HR, Johnson RN, Fu AD, Lujan BJ, Cunningham ET Jr. Emerging concepts in the management of acute retinal necrosis. Br J Ophthalmol 2012, Dec 21. [Epub ahead of print].
  179. Doshi RR, Schwab IR, Harocopos GJ, Cunningham ET Jr. Surgically induced necrotizing scleritis with Scedosporium superinfection following pterygium excision with beta-radiation. Survey of Ophthalmology 2012, In Press.
  180. Hoang QV, Cunningham ET Jr, Sorenson JA, Freund KB. The “pitchfork sign” – A distinctive optical coherence tomography finding in inflammatory choroidal neovascularization. Retina 2012, In Press.
  181. Cunningham ET Jr, Eandi CM, Wender JD. HIV status and outcomes in patients with ocular syphilis. Retina 2012, In press.
  182. London NJS, Garg SJ, Moorthy R, Cunningham ET Jr. Drug-induced uveitis. J Ophthalmic Inflamm Infect 2013; Submitted.
  183. Wender JD, Jumper JM, McDonald HR, Fu AD, Johnson RN, Lujan BJ, Cunningham ET Jr. Ocular syphilis. Retina 2012; In preparation.
  184. Wong RW, Jumper JM, McDonald HR, Johnson RN, Fu A, Lujan BJ, Cunningham ET Jr. Emerging concepts in the management of acute retinal necrosis. Postgrad Med J 2013; 89(1054):478-485.
  185. Doshi RR, Schwab IR, Harocopos GJ, Cunningham ET Jr. The spectrum of postoperative scleral necrosis. Surv Ophthalmol 2013; 58(6):620-633.
  186. Pichi F, Ciardella AP, Cunningham ET Jr, Morara M, Veronese C, Jumper JM, Albini TA, Sarraf D, McCannel C, Voleti V, Choudhry N, Bertelli E, Giuliari GP, Souied E, Amer R, Regine F, Ricci F, Neri P, Nucci P. Spectral Domain Optical Coherence Tomography findings in patients with acute syphilitic posterior placoid chorioretinopathy. Retina 2014; 34(2):373-384.
  187. DeNiro JE, Fu AD, Johnson RN, McDonald HR, Jumper JM, Cunningham ET Jr, Lujan BJ. Intravitreous Ranibizumab for Persistent Macular Edema in Retinal Vein Occlusion Unresponsive to Bevacizumab. Retinal Cases & Brief Reports, 2013; 7(3):220-224.
  188. Cunningham ET Jr, Eandi CM, Pichi F. Syphilitic uveitis. Ocul Immunol Inflamm 2014; 22(1):2-3.
  189. De Niro JE, McDonald HR, Johnson RN, Jumper JM, Fu AD, Cunningham ET Jr, Lujan BJ. Sensitivity of fluid detection in patients with neovascular AMD using spectral domain optical coherence tomography high-definition line scans. Retina 2014 Jan 8. [Epub ahead of print]
  190. Hoang QV, Cunningham ET Jr, Sorenson JA, Freund KB. The “pitchfork sign” – A distinctive optical coherence tomography finding in inflammatory choroidal neovascularization. Retina 2013; 33(5):1049-1055.
  191. Cunningham ET Jr, Eandi CM, Wender JD. Re: Ocular manifestations of syphilitic uveitis in Chinese patients. Retina. 2013; 33(2):451.
  192. Zierhut M, Heiligenhaus A, deBoer J, Cunningham ET Jr, Tugal-Tutkun I. Controversies in juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Inflamm 2013; 21(3):167-179.
  193. Tugal-Tutkun I, Gupta V, Cunningham ET Jr. Differential diagnosis of Behcet uveitis. Ocul Immunol Inflamm 2013; 21(5):337-350.
  194. London NJS, Garg SJ, Moorthy R, Cunningham ET Jr. Drug-induced uveitis. J Ophthalmic Inflamm Infect 2013; 25;3(1):43
  195. Eandi CM, Bertelli E, Cunningham ET Jr. Comment re: Unilateral solitary choroidal granuloma as presenting sign of secondary syphilis. Graefes Arch Clin Exp Ophthalmol, 2013; 251(9):2289-2290.
  196. Fung AT, Yannuzzi NA, Christos P, Cooney M, Slakter JS, Klancnik JM, Freund KB, Cunningham ET Jr, Yannuzzi LA. Multifocal choroiditis without panuveitis: Clinical characteristics and progression. Retina 2014; 34(1):98-107.
  197. Jung JJ, Khan S, Mrejen S, Gallego-Pinazo R, Cunningham ET Jr, Freund KB, Jampol LM, Yannuzzi LA. Idiopathic multifocal choroiditis with outer retinal or chorioretinal atrophy. Retina 2013 Dec 27. [Epub ahead of print]
  198. Cunningham ET Jr. Treatment of chronic noninfectious uveitis in children – the trend toward TNF-α inhibition. J AAPOS 2013; 17(5):451-453.
  199. Cunningham ET Jr, Eandi CM, Pichi F. Syphilitic uveitis. Ocul Immunol Inflamm 2014; 22(1):2-3.
  200. Cunningham ET Jr, Zierhut M. The promise and limitations of TNF-α inhibition in uveitis. Ocul Immuno Inflamm 2014; 22(2):87-89.
  201. Takakura A, Tessler HH, Goldstein DA, Guex-Crosier Y, Chan CC, Brown DM, Thorne JE, Wang R, Cunningham ET Jr. Viral retinitis following intraocular and periocular corticosteroid administration – A case series and comprehensive review of the literature. Ocul Immuno Inflamm 2014; Mar 21. [Epub ahead of print]
  202. Takakura A, Haug SJ, Radhakrishnan, Fu AD, Jumper JM, McDonald HR, Johnson RN, Lujan BJ, Cunningham ET Jr. Central serous chorioretinopathy following trabeculectomy in a patient with microphthalmos and congenital rubella syndrome. Retinal Cases & Brief Reports, 2014, 8:153-156.
  203. Clamp MF, Wilkes G, Leis LS, McDonald HR, Johnson RN, Jumper JM, Fu AD, Cunningham ET Jr, Stewart PJ, Haug SJ, Lujan BJ. En face spectral domain optical coherence tomography analysis of lamellar macular holes. Retina 2014; Mar 24. [Epub ahead of print]
  204. Coady PA, Cunningham ET Jr, Vora RA, McDonald HR, Johnson RN, Jumper JM, Fu AD, Haug SJ, Williams SL, Lujan BJ Spectral domain optical coherence tomography findings in eyes with acute ischaemic retinal whitening. Br J Ophthalmol. 2014 Jul 3. pii: bjophthalmol-2014-304900. doi: 10.1136/bjophthalmol-2014-304900. [Epub ahead of print]
  205. Boyer DS, Goldbaum M, Leys AM, Starita C; for the V.I.S.I.O.N. Study Group. Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study. Br J Ophthalmol. 2014 Jul 4. pii: bjophthalmol-2013-304075. doi: 10.1136/bjophthalmol-2013-304075. [Epub ahead of print]
  206. Haug SJ, Takakura A, Jumper JM, Heiden D, McDonald HR, Johnson RN, Fu AD, Lujan BJ, Cunningham ET Jr. Rhegmatogenous retinal detachment in patients with acute syphilitic panuveitis. Ocul Immuno Inflamm 2014, Jun 24:1-8.
  207. Takakura A, Stewart PJ, Johnson RN, Cunningham ET Jr. Purtscher’s-like retinopathy following prostate surgery. Retinal Cases & Brief Reports, 2014 Fall; 8(4):245-246.
  208. Clamp MF, Jumper JM, Ku CW, McDonald HR, Johnson RN, Fu AD, Lujan JL, Cunningham ET Jr. Chronic exogenous Exophiala dermatitidis endophthalmitis. Retinal Cases & Brief Reports, 2014 Fall; 8(4):265-268.
  209. Williams SL, McDonald HR, Jumper JM, Fu AD, Lujan BJ, Cunningham ET Jr, Johnson RN. Paraneoplastic vitelliform retinopathy in a patient with treated choroidal melanoma. Retin Cases Brief Rep. 2014 Fall; 8(4):269-272
  210. Dokey AT, Haug SJ, McDonald HR, Cunningham ET Jr, Lujan BJ, Fu AD, Jumper JM. Acute retinal necrosis secondary to multidrug-resistant herpes simplex virus 2 in an immunocompetent adolescent. Retin Cases Brief Rep. 2014 Fall; 8(4):260-264.
  211. Cunningham ET Jr, van Velthoven ME, Zierhut M. Spectral-domain-optical coherence tomography in uveitis. Ocul Immunol Inflamm. 2014 Dec; 22(6):425-428.
  212. Wender JD, Jumper JM, McDonald HR, Fu AD, Johnson RN, Lujan BJ, Cunningham ET Jr. Ocular syphilis. Retina 2014; In preparation.
  213. London NJS, Garg SJ, Moorthy R, Cunningham ET Jr. Drug-induced uveitis. J American Academy of Ophthalmology, Focal Points 2014, Submitted.
  214. Cunningham ET Jr, Wong RW, Takakura A, Downes KM, Zierhut M. Necrotizing herpetic retinitis. Ocul Immuno Inflamm 2014; 22(3):167-169.
  215. Cunningham ET Jr, Rathinam SR, Tugal-Tutkun I, Muccioli C, Zierhut M. Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2014; 22(4):249-252.
  216. Cunningham ET Jr, Lowder CY, Miserocchi E, Thorne JE, Zierhut M. Sarcoid uveitis. Ocul Immunol Inflamm. 2014; 22(4):253-256.
  217. Kasi SK, Kim HJ, Basham RP, Cunningham ET Jr, Sy A, Lustig L, Kersten RC. Idiopathic Orbital Inflammation Associated With Necrotizing Scleritis and Temporal Bone Inflammation. Ophthal Plast Reconstr Surg. 2014 Aug 14. [Epub ahead of print]
  218. Agrawal R, De Salvo G, Pavlidou E, Smith R, Pavesio C, Cunningham ET Jr, Shields CL. Diagnostic and Therapeutic Challenges. Retina 2014 Jul 30. [Epub ahead of print].
  219. Avery RL, Bakri SJ, Blumenkranz MS, Brucker AJ, Cunningham ET Jr, DʼAmico DJ, Dugel PU, Flynn HW Jr, Freund KB, Haller JA, Jumper JM, Liebmann JM, McCannel CA, Mieler WF, Ta CN, Williams GA. INTRAVITREAL INJECTION TECHNIQUE AND MONITORING: Updated Guidelines of an Expert Panel. Retina. 2014 Dec; 34 Suppl 12:S1-S18.
  220. Cunningham ET Jr, Rathinam SR, Albini TA, Chee SP, Zierhut M. Tuberculous uveitis. Ocul Immunol Inflamm. 2015 Feb; 23(1):2-6.
  221. Cunningham ET Jr, Belfort R Jr, Muccioli C, Arevalo JF, Zierhut M. Ocular Toxoplasmosis. Ocul Immunol Inflamm. 2015 Jun; 23(3):191-193.
  222. Marsiglia M, Gallego-Pinazo R, Cunha de Souza E, Munk MR, Yu S, Mrejen S, Cunningham ET Jr, Lujan B, Goldberg NR, Albini TA, Gaudric A, Francais C, Rosen RB, Freund KB, Jampol LM, Yannuzzi LA. Expanded clinical spectrum of multiple evanescent white dot syndrome with multimodal imaging. Retina. 2015 Jul 8. [Epub ahead of print]
  223. Cunningham ET Jr, Acharya NA, Kempen JH, Zierhut M. Design and interpretation of clinical studies in uveitis. Ocul Immunol Inflamm. 2015. In press.

Non-Refereed Publications
  1. Sawchenko PE, Cunningham ET Jr, Levin MC. Anatomical and biochemical specificity in central autonomic pathways. In: C. Polosa and F. Calaresu (eds.), Organization of the Autonomic Nervous System: Central and Peripheral Mechanisms 1987; New York, Alan R. Liss, pp. 267-281.
  2. Sawchenko PE, Cunningham ET Jr, Mortrud MT, Pfeiffer SW and Gerfen CR. The Phaseolus Vulgaris-leucoagglutinin (PHA-L) anterograde axonal transport technique. In: P.M. Conn (ed.), Methods in Neuroscience Vol. 2 1990; New York, CRC Press. Chapter 13, pp. 247-260.
  3. Cunningham ET Jr, Donner MW, Jones B, Point SW. Anatomical and Physiological Overview. In: B. Jones and M.W. Donner (eds.), Normal and Abnormal Swallowing:Imaging in Diagnosis and Therapy 1990; New York, Springer-Verlag. Chapter 2, pp. 7-32.
  4. Point SW, Bryan RN, Zinreich SJ, Cunningham ET Jr. An Integrated approach to cross-sectional imaging and dysphagia (CT and MRI). In: B. Jones and M.W. Donner (eds.), Normal and Abnormal Swallowing: Imaging in Diagnosis and Therapy 1990; New York, Springer-Verlag. Chapter 9, pp. 119-146.
  5. De Souza EB, Takao T, Cunningham ET Jr, Webster EL, Grigoriadis DE, Tracey DE. Interleukin-1 (IL-1) and corticotropin-releasing hormone (CRH) receptors in the brain-endocrine-immune axis: role in mediating stress response. In: R. Kvetnansky, R. McCarty and J. Axelrod (eds.), Stress: Neurochemical and Molecular Approaches 1992; New York, Gordon and Breach, pp. 665-684.
  6. Sawchenko PE, Cunningham ET Jr, Bittencourt JC, Chan RKW. Aminergic and peptidergic pathways subserving the stress response. In: R. Kvetnansky, R. McCarty and J. Axelrod (eds.), Stress: Neurochemical and Molecular Approaches 1992; New York, Gordon and Breach, pp. 15-27.
  7. Cunningham ET Jr, De Souza EB. Localization of type I receptor mRNA in brain and endocrine tissues using in situ hybridization histochemistry. In: E. B. De Souza (ed.), Methods in Neuroscience. Neurobiology of Cytokines 1993; New York, CRC Press. Chapter 7, pp. 112-127.
  8. Cunningham ET Jr, Jones B, Donner MW. Pharynx: Normal anatomy and techniques of examination. In: P.C. Freeny and G.W. Steveson (eds.), Margulis and Burhenne's Alimentary Tract Radiology, 5th. Edition 1993; St. Louis, C.V. Mosby Co., Vol. 1, Chapter 4, pp. 94-113
  9. Cunningham ET Jr, Nozik RA. Uveitis: Diagnostic approach and ancillary analysis. In: Duane's Clinical Ophthalmology 1998; Volume 4, External Diseases and The Uvea, Chapter 37. Schwab IR and Tessler HH (Volume editors), Tasman W and Jaeger EA (Series editors). Pages 1-25.
  10. Cunningham ET Jr, Margolis TP. Ocular manifestations of HIV infection. In: Duane's Clinical Ophthalmology, Volume 4, Immunology and Allergy Section 1998; Chapter 36. Mitchell Friedlaender (Volume editor), Tasman W and Jaeger EA (Series editors). Pages 1-20.
  11. Cunningham ET Jr. Uveal Tract and Sclera. (1999) In: General Ophthalmology, Fifteenth Edition 1999; Vaughan DG, Asbury T, and Riordan-Eva P, Eds. Appleton & Lange, Stamford, Connecticut, Chapter 7, 142-158.
  12. Cunningham ET Jr. Rational Approach to Diagnosing Uveitis. Review of Ophthalmology 1999; January:46-55.
  13. Acharya NR, Cunningham ET Jr. Corneal, anterior segment, and adnexal manifestations of HIV infection. International Ophthalmology Clinics 1999; 38(4):161-177.
  14. Kuo I.C, Cunningham ET Jr. How to manage VKH. Review of Ophthalmology 1999; April, 192-194.
  15. Cunningham ET Jr, Nozik RA. Uveal Tract: Uveitis. In: The Merck Manual, Edition 17 1999; Chapter 98, 725-729.
  16. Cunningham ET Jr, Pepose JS, Holland GN. Cytomegalovirus infections of the retina. In: Retina, Volume Two, Medical Retina, Third Edition, Chapter 95. 1999; S.J. Ryan, Editor-in Chief, A.P. Schachat and R.P. Murphy, Volume Editors, Mosby, St. Louis, Missouri.
  17. Cunningham ET Jr. Ocular complications of HIV infection. In: The Medical Management of AIDS, Sixth Edition. 1999; M.A. Sande and P.A. Volberding, Editors, Philadelphia, W.B. Saunders, Co., Chapter 11, 171-184.
  18. Cunningham ET Jr. Ocular Manifestations of Systemic Disease. Editorial Overview. Current Opinion in Ophthalmology 1999; 10:429-430.
  19. Kuo IC, Cunningham ET Jr. Ocular neovascularization in patients with uveitis. International Ophthalmology Clinics 2000; 40(2):111-126.
  20. Gaynor BC, Margolis TP, Cunningham ET Jr. Advances in the diagnosis and management of herpetic uveitis. International Ophthalmology Clinics 2000; 40(2):85-109.
  21. Rathinam SR, Cunningham ET Jr. Infectious causes of uveitis in the developing world. International Ophthalmology Clinics 2000; 40(2):137-152.
  22. Cunningham ET Jr. Treating intermediate and posterior uveitis. Review of Ophthalmology 2001; October, 100-104.
  23. Cunningham ET Jr, Jones B. Anatomical and Physiological Overview. In: B. Jones (ed.), Normal and Abnormal Swallowing: Imaging in Diagnosis and Therapy, Second Edition 2003; New York, Springer. Chapter 2, pp 11-34.
  24. Read RW, Rao NA, Cunningham ET Jr. Vogt-Koyanagi-Harada disease. Current Opinion in Ophthalmology 2001; 11(6):437-442.
  25. Siverio CD, Cunningham ET Jr. Patogenesis de la infeccion por HIV. In: Manifestaciones Oculares del SIDA en el Nuevo Milenio 2001; Arevalo JF (ed). In Press.
  26. Aldave AJ, King JA, Cunningham ET Jr. Ocular Syphilis. Curr Opin Ophthalmol 2001; 12(6):433-441.
  27. Cunningham ET Jr. Comment on: Changes in the ocular and nasal signs and symptoms of aircrews in relation to the ban on smoking on intercontinental flights. By Wieslander G, Lindgren T, Norback D, Venge P. Scan J Work Environ Health 2000; 26:514-522. Surv Ophthalmol 2001; 46(3):298.
  28. Siverio CD, Imai Y, Cunningham ET Jr. Diagnosis and management of herpetic anterior uveitis. Intern Ophthalmol Clin 2002; 42(1):43-48.
  29. Hovakimyan A, Cunningham ET Jr. Ocular toxoplasmosis. Ophthalmol Clin North Am 2002; 15(3):327-2332.
  30. Ciardella AP, Borodoker N, Costa DL, Huang SJ, Cunningham ET Jr, Slakter JS. Imaging the posterior segment in uveitis. Ophthalmol Clin North Am 2002; 15(3): 281-296.
  31. Smith J, Cunningham ET Jr. Atypical toxoplasmosis. Curr Opin Ophthalmol 2002; 13:387-392.
  32. Shukla D, Rajendran A, Singh J, Ramasamy K, Namperumalsamy P, Cunningham ET Jr. Atypical manifestations of diabetic retinopathy. Curr Opin Ophthalmol 2003; 14:371-377.
  33. Lustig M, Cunningham ET Jr. Use of immunosuppressive agents in uveitis. Curr Opin Ophthalmol 2003; 14:399-412.
  34. Cunningham ET Jr. Uveal tract and sclera. In: Vaughan & Asbury's General Ophthalmology. 2004 Sixteenth Edition. Riordan-Eva P, Whitcher JP, eds. Appleton & Lange, Stamford, Connecticut, Chapter 7, 154-172.
  35. Cunningham ET Jr, Regillo C (Editors). A Clinician's Guide to Retinal Disease. Rev Ophthalmol 2004 vol. 9 (suppl.).
  36. Ng G, Cunningham ET Jr, Adamis AT, Guyer DR. Macugen (pegaptanib sodium injection). In: Age-Related Macular Degeneration; Alfaro DV III, Liggett PE, Mieler WF, Quiroz-Mercado H, Jager RD, Tano Y (eds). 2006. Lippincott Williams & Wilkins, Philadelphia, PA. Chapter, 23, 271-285.
  37. Roe R, Fisher C, Cunningham ET Jr. Behcet’s disease: A Case of Floaters and Fevers. Eyenet: Morning Rounds 2006: May, 43-44.
  38. Rathinam SR, Cunningham ET Jr. Leptospirosis. In: Current Ocular Therapy, 6th Edition. Roy FH, Fraunfelder FW, Fraunfelder FT, eds. Saunders Elsevier, London, England, Chapter 24, 45-47.
  39. Regillo C, Cunningham ET Jr (Editors). AMD 2005: Evolving treatment options. Rev Ophthalmol 2005 vol. 12 (suppl.), December.
  40. Cunningham ET Jr. Section 9: Eye Disorders: Uveitis. In: The Merck Manual Professional Edition, Edition 18, Publisher, Merck & Co., Inc., Whitehouse Station, NJ. 2006; Chapter 105, 912-916.
  41. Gasperine J, Eliott D, Cunningham ET Jr. Chorioretinal folds. Retinal Insider 2006, November, pp 75-80.
  42. Stewart J, Cunningham ET Jr. Ocular toxocariasis. Retinal Insider 2006, January, pp 56-59.
  43. Regillo C, Cunningham ET Jr (Editors). AMD 2006: Building hope, improving vision. Rev Ophthalmol 2006 , vol. 12 (suppl.), pp 1-32.
  44. Zeleksky JR, Teng CC, Cunningham ET Jr. Sudden, bilateral loss of vision in an elderly Chinese woman. EyeNet, Morning Rounds. May, 2007, pp 51-52.
  45. Shukla D, Rathinam SR, Cunningham ET Jr. Contributions of HIV/AIDS to global blindness. International Ophthalmology Clinics 2007; 47(3):27-43.
  46. Huang C, Park S, Castellarin AA, Pieramici DJ, Cunningham ET Jr. Diagnostic and Therapeutic Challenges. Retina 2007; 27(3):385-390.
  47. Nair, U., J. Aldave A and E. T. Cunningham Jr. "Identifying Intraocular Foreign Bodies." EyeNet 2007; 11(8):31-32.
  48. Roe RH, Jumper MJ, Fu AR, McDonald HR, Johnson JN, Cunningham ET Jr. Ocular Bartonella. International Ophthalmology Clinics 2008, 48(3):93-105.
  49. Cunningham ET Jr, Oz O, Akduman L. Uveitte tedavi prensipleri (Uveitis treatment principles). In: Uveit el Kitabi. Akduman L, Aydin O'Dwyer P (eds). Gunes Tip Kitabevleri. Istanbul, Turkey. 2008.
  50. Han SB, Kim JH, Kim S-J, Yu YS, Cunningham ET Jr. Diagnostic and Therapeutic Challenges. Retina 2008; 28(8):1166-9.
  51. Cunningham ET Jr. Uveal tract and sclera. In: Vaughan & Asbury's General Ophthalmology. 2008 17th Edition. Riordan-Eva P, Whitcher JP, eds. Appleton & Lange, Stamford, Connecticut, Chapter 7, 151-163.
  52. Arevalo FJ, Garcia RA, Alexandre de Amorim Garcia C, Orefice F, Curi A, Sanchez JG, Cunningham ET Jr. Neuroretinitis subaguda unilateral difusa. Chapter 18. In: Uveitis y tumors intraoculares: Temas Selectos. Arevalo JF, Graue-Wiechers F, Quiroz-Mercado H, Rodriguez FJ, and Wu L (Editors). Amolca, Venezuela. 2008.
  53. Cunningham ET Jr. "Uveitis" in The Merck Manual of Medical Information, 3rd Home Edition, Merck Research Laboratories, Division of Merck & Co., Inc., Whitehouse Station, NJ, in press (continuously updated at www.merckmanuels.com).
  54. Cunningham ET Jr. "Uveitis" in The Merck Manual of Diagnosis and Therapy, 18th Edition, Merck Research Laboratories, Division of Merck & Co., Inc., Whitehouse Station, NJ, in press (continuously updated at www.merckmanuels.com).
  55. Zelefsky JR, Cunningham ET Jr. Evaluation and management of elevated IOP in patients with uveitis. American Academy of Ophthalmology, Focal Points 2010, Volume XXVIII, number 6 (Section 3 of 3).
  56. Sadhakrishnan S, Cunningham ET Jr, Iwach A. Inflammatory disease and glaucoma. In: The Glaucoma Book: A Practical, Evidence-Based Approach to Patient Care. Schacknow PN and Samples JR (Editors), Springer, Berlin. 2010; chapter 41, pp. 527-536.
  57. Goldbaum M, Cunningham ET Jr. Aptamers and Intramers: Pegaptanib. In: Retinal Pharmacotherapy. Nguyen QD, Rodrigues EB, Farah ME, and Mieler WF (Editors). Elsevier, London, 2009, Chapter 38, pp. 265-272.
  58. Wender JD, Eliott D, Jumper JM, Cunningham ET Jr. How to recognize ocular syphilis. Retinal Insider, Review of Ophthalmology November, 2008, 124-130.
  59. Pomerleau D, Jumper JM, Cunningham ET Jr. Coats Disease: Diagnosis and Management. Retinal Insider, Review of Ophthalmology December, 2009, 50-52,57.
  60. London NJS, Rathinam SR, Cunningham ET Jr. The epidemiology of uveitis in developing countries. International Ophthalmology Clinics 2010; 50(2):1-17.
  61. Sabrosa NA, Cunningham ET Jr, Arevalo JF. Ocular nematode and trematode infections in the developing world. International Ophthalmology Clinics 2010; 50(2):71-86.
  62. Shukla D, Rathinam SR, Cunningham ET Jr. Leptospiral uveitis in the developing world. International Ophthalmology Clinics 2009, 50(2):113-124.
  63. Hovakimyan A, Baglivo E, Cunningham ET Jr. Fuchs uveitis syndrome in the developing world. International Ophthalmology Clinics 2009, 50(2):145-154.
  64. London NJS, Dhananjay S, Heiden D, Rathinam SR, Arevalo JF, Cunningham ET Jr. HIV/AIDS in the developing world. International Ophthalmology Clinics 2010; 50(2):201-218.
  65. Cunningham ET Jr, Wender JD. Practical approach to the use of corticosteroids in patients with uveitis. Can J Ophthalmol 2010, In press.
  66. Nair U, Cunningham ET Jr. Uveitis: Diagnostic and Ancillary Approach. In: Duane's Clinical Ophthalmology, Volume 4, Immunology and Allergy Section 2010; Mitchell Friedlaender (Volume editor), Tasman W and Jaeger EA (Series editors). Lippincott Williams & Wilkins, Philadelphia, 2010, In press.
  67. London NJS, Cunningham ET Jr. Ocular manifestations of HIV/AIDS. In: Duane's Clinical Ophthalmology, Volume 4, Immunology and Allergy Section 2010; Mitchell Friedlaender (Volume editor), Tasman W and Jaeger EA (Series editors). Lippincott Williams & Wilkins, Philadelphia, 2010, In press.
  68. Fu AJ, Jumper JM, McDonald RM, Johnson RN, Ai E, Cunningham ET Jr. In: Duanes Ophthalmology. Acquired Macular Disease, Chapter 23. Lippincott Williams & Wilkins, Philadelphia, 2010.
  69. London NJS, Cunningham ET Jr. Uveitis in immunocompromised patients. In: Intraocular Inflammation. Zierhut M, Ohno S, Orefice F, Pavesio C, Rao N (Eds). Springer-Verlag, London. 2010, in press.
  70. London NJS, Cunningham ET Jr. HIV. In: Intraocular Inflammation. Zierhut M, Ohno S, Orefice F, Pavesio C, Rao N (Eds). Springer-Verlag, London. 2010, in press.
  71. London NJS, Cunningham ET Jr. Pneumocystosis. In: Intraocular Inflammation. Zierhut M, Ohno S, Orefice F, Pavesio C, Rao N (Eds). Springer-Verlag, London. 2010, in press.
  72. London NJS, Cunningham ET Jr. Neuroretinitis. In: Intraocular Inflammation. Zierhut M, Ohno S, Orefice F, Pavesio C, Rao N (Eds). Springer-Verlag, London. 2010, in press.
  73. Wender JD, Cunningham ET Jr. Borreliosis. In: Intraocular Inflammation. Zierhut M, Ohno S, Orefice F, Pavesio C, Rao N (Eds). Springer-Verlag, London. 2009, in press.
  74. Nair U, Moorthy RS, Cunningham ET Jr. Histoplasmosis. In: Intraocular Inflammation. Zierhut M, Ohno S, Orefice F, Pavesio C, Rao N (Eds). Springer-Verlag, London. 2010,.
  75. Roe RH, Jumper JM, Fu AD, Johnson RN, McDonald HR, Cunningham ET Jr. Bartonella. In: Intraocular Inflammation. Zierhut M, Ohno S, Orefice F, Pavesio C, Rao N (Eds). Springer-Verlag, London. 2010,.
  76. Zelefsky JD, Cunningham ET Jr. Mooren’s ulcer. In: Uveitis – Color Atlas and Synopsis of Clinical Ophthalmology – Wills Eye Institute, Second Edition. Garg S (Editor); Bodaghi B, Nussenblatt R, Rathinam SR, Sen HN (Section Editors). Lippincott Williams & Wilkins, Philadelphia, 2011, 28-30.
  77. Wong R, Rathinam SR, Cunningham ET Jr. Systemic lupus erythematosus. In: Uveitis – Color Atlas and Synopsis of Clinical Ophthalmology – Wills Eye Institute, Second Edition. Garg S (Editor); Bodaghi B, Nussenblatt R, Rathinam SR, Sen HN (Section Editors). Lippincott Williams & Wilkins, Philadelphia, 2011, 91-94.
  78. Doshi R, Rathinam SR, Cunningham ET Jr. Sympathetic ophthalmia. In: Uveitis – Color Atlas and Synopsis of Clinical Ophthalmology – Wills Eye Institute, Second Edition. Garg S (Editor); Bodaghi B, Nussenblatt R, Rathinam SR, Sen HN (Section Editors). Lippincott Williams & Wilkins, Philadelphia, 2011, 72-75.
  79. Arevalo JF, Belfort R Jr, Espinoza JV, Muccioli C, Cunningham ET Jr. Retinal and choroidal manifestations of toxoplasmosis. In: Retinal and Choroidal Manifestations of Selected Systemic Diseases. Arevalo JF, Editor. Springer, New York, 2013. Chapter 6, pp79-104.
  80. Arevalo JF, Garcia RA, Tata LS, de Amorim Garcia A, Orefice F, Curi A, Cunningham ET Jr. Diffuse unilateral subacute neuroretinitis (DUSN). In: Retinal and Choroidal Manifestations of Selected Systemic Diseases. Arevalo JF, Editor. Springer, New York, 2013. Chapter 2, pp23-35.
  81. Arevalo JF, Garcia RA, London NJS, Cunningham ET Jr, Belfort R Jr, Freeman WR. Retinal and choroidal manifestations of AIDS. In: Retinal and Choroidal Manifestations of Selected Systemic Diseases. Arevalo JF, Editor. Springer, New York, 2013. Chapter 1, pp1-22.
  82. Cunningham ET Jr. What diseases should I consider in a patient with neuroretinitis? In: Curbside Consultation in Uveitis. Foster CS (Editor). Hinkle DM and Opremcak EM (Associate Editors). Slack Book Incorporated. Thorofare, NJ. 2012, Chapter 27, 103-106.
  83. Salz D, Prenner J, Cunningham ET Jr. Local complications of IV anti-VEGF therapy. Review of Ophthalmology. November, 2010: 66-75.
  84. Chappell MC, Jumper JM, McDonald HR, Cunningham ET Jr. Spotting Bartonella-associated uveitis. Review of Ophthalmology. March, 2011: 112-117.
  85. Chan P, Iranmanesh R, Cunningham ET Jr. The case of the blurry-eyed graphic designer. EyeNet. April, 2011:47-48.
  86. Gess A, Wender J, Jumper JM, Cunningham ET Jr. The red eye from Rio. EyeNet. May, 2011:1-2
  87. Cunningham ET Jr, Kestelyn, P, Pavesio CE. Ocular manifestations of HIV/AIDS in children. In: Hoyt C and Taylor D Eds; Pediatric Ophthalmology and Strabismus, Fourth Saunders Ltd., London, UK. 2012, Chapter 16, 132-138.
  88. Zelefsky JR, Cunningham ET Jr. The surgical management of uveitic glaucoma. In: Eliot D, Rao PK (eds). Surgical Management of Intraocular Inflammation and Infection. London: JP Medical Ltd, 2013. Chapter 2, 9-13.
  89. Cunningham ET Jr, Augsburger JJ, Correa ZM, Pavesio C. Uveal tract and sclera. In: Vaughan & Asbury's General Ophthalmology. 2011 18th Edition. Riordan-Eva P, Cunningham ET Jr.
  90. Fu AD, Ai E, McDonald HR, Johnson RN, Jumper JM, Cunningham ET Jr, Lujan B. Hereditary macular dystrophies. In: Duane's Clinical Ophthalmology 2012, In press.
  91. Cunningham ET Jr. Future therapies for chronic noninfectious uveitis. Retina Today, November/December, 2012, 1-7.
  92. Cunningham ET Jr, “Uveitis,” in The Merck Manual Home Health Handbook, John Wiley & Sons, Inc., last published 2009, updated continuously online at www.merckmanuals.com/home.
  93. Cunningham ET Jr, “Uveitis,” in The Merck Manual of Diagnosis and Therapy, Merck Sharp & Dohme Corp., last published 2011, changed to “Uveitis and Related Disorders” and updated continuously online at www.merckmanuals.com/professsional
  94. Wong RW, Cunningham ET Jr. Posterior segment findings in SLE. Review of Ophthalmology 2013, January, 41-45.
  95. Wong RW, Jumper JM, McDonald HR, Johnson RN, Fu A, Lujan BJ, Cunningham ET Jr. Emerging concepts in the management of acute retinal necrosis. Postgrad Med J 2013; 89(1054):478-485.
  96. Zelefsky JR, Cunningham ET Jr. Spotlight: Uveitic Glaucoma, for “Uveitic Glaucoma” by Avinash Kulkarni and Keith Barton, Chapter 36. In: Glaucoma, Volume 1, Medical Diagnosis & Therapy, Second Edition. Edited by Tarek Shaarawy, Mark B Sherwood, Roger Hitchings and Jonathan G. Crowston. Elsevier Limited, London, In press, 2013.
  97. Radhakrishnan S, Cunningham ET Jr, Iwach A. Inflammatory disease and glaucoma. In: Samples J and Schacknow P, eds. Clinical Glaucoma Care – The Essentials. Springer; 2014:375-90.
  98. Moorthy RS, London NJS, Garg SJ, Cunningham ET Jr. Drug-induced uveitis. Curr Opin Ophthalmol 2013; 24(6):589-597.
  99. Halfter W, Cunningham ET Jr, Sebag J: Vitreo-retinal interface and ILM. In: Vitreous – in Health and Disease ( J Sebag, ed). Springer, 2014, in press.
  100. McCannel CA, Flynn HW Jr, Cunningham ET Jr. Updated guidelines for intravitreal injection. Retinal Insider, July, 2015, pp 52-55.
  101. Cunningham ET Jr, Shields CL, Shields JA. Masquerade syndromes in uveitis. In: Uveitis: A Practical Guide for the Treatment of Ocular Inflammation. George N Papaliodis, MD, Editor; Springer (New York); (Chapter – Submitted; December 14, 2014)

TEXTBOOKS AND MONOGRAPHS
  1. International Ophthalmology Clinics. Advances in Uveitis. Cunningham ET Jr (Guest Editor). Spring 2000; Volume 40(2).
  2. Bulletin of the World Health Organization. Guest Editors: Cunningham ET Jr, Leitman T, Whitcher JP; Blindness Theme Issue; 2001:79(3).
  3. HIV/AIDS and the Eye: A Global Perspective Cunningham ET Jr, Belfort R Jr. Ophthalmology Monograph 15. San Francisco: American Academy of Ophthalmology; 2002.
  4. International Ophthalmology Clinics. Advances in Infectious and Inflammatory Eye Disease. Cunningham ET Jr, Ohno S (Guest Editors). 2002, Volume 42(1).
  5. Ophthalmology Clinics of North America. Uveitis Update. Cunningham ET Jr (Guest Editor). 2002, Volume 15(3).
  6. International Ophthalmology Clinics. Recent Advances in Ocular Therapeutics. Cunningham ET Jr, Ng EWM (Guest Editors). 2006, Volume 46(4).
  7. International Ophthalmology Clinics. Uveitis in children. Arellanas-Garcia L, Cunningham ET Jr (Guest Editors). 2008, Volume 49(3).
  8. International Ophthalmology Clinics. Uveitis in the Developing World. Arevalo JF, Chee SP, Cunningham ET Jr, Kestelyn P, Rathinam SR (Guest Editors). 2010, Volume 50(2).
  9. Vaughan & Asbury’s General Ophthalmology, 18th Edition. Riordan-Eva P, Cunningham ET Jr. (Editors). 2011. New York, McGraw Hill Medical.
  10. International Ophthalmology Clinics. Imaging in the Diagnosis and Management of Uveitis. Cunningham ET Jr (Guest Editor). 2012, 52(4).
  11. Retina and Vitreous. American Academy of Ophthalmology, Basic and Clinical Science Course, Section 12. Faculty writing committee, 2013-2017. In press to be published 2015.

ABSTRACTS
  1. Daily RN, Jacobson M, Cunningham ET Jr, Davis FA, Baker GT III. Effect of vitamin E on survivorship of a DNA repair deficient mutant of Drosophila Melanogaster. In: R.C. Adelman, G.T. Baker, III, V. Cristobal and J. Robersts (eds.), Neuralregulatory Mechanisms During Aging 1980; New York, Alan R. Liss (Abstract).
  2. Cunningham ET Jr, Sawchenko PE. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. Anat Rec 1986; 214:27A (Abstract).
  3. Cunningham ET Jr, Sawchenko PE. Local projections from the medial part of the nucleus of the solitary tract. Absts Soc Neurosci 1986; 12:1364 (Abstract).
  4. LeVay S, Cunningham ET Jr. Projection of thalamic nucleus centralis to primary visual cortex in the cat. Absts Soc Neurosci 1986; 12:1055 (Abstract).
  5. Cunningham ET Jr, Sawchenko PE. Projections from the C1, C2 and C3 adrenergic cell groups to the paraventricular and supraoptic nuclei of the rat hypothalamus. Anat Rec 1987; 218:29A (Abstract).
  6. Cunningham ET Jr, Sawchenko PE. Forebrain projections of the nucleus of the solitary tract in the rat. Neurosci 1987; 22 (suppl.): S774 (Abstract).
  7. Levin MC, Cunningham ET Jr, Sawchenko PE. The Organization of mesencephalic and pontine afferents to the paraventricular and supraoptic nuclei in the rat. Absts Soc Neurosci 1987; 13:1166 (Abstract).
  8. Sawchenko PE, Pfeiffer SW, Plotsky PM, Roberts VJ, Cunningham ET Jr, Benoit R, Brown MR, Vale W. Inhibin b- and somatostatin-28-immunoreactive projections from the nucleus of the solitary tract to oxytocinergic cell groups. Absts Soc Neurosci 1988; 14:442 (Abstract).
  9. Cunningham ET Jr, Benoit R, Sawchenko PE. Evidence for a somatostatinergic projection from the nucleus of the solitary tract to the nucleus ambiguus in the rat. Absts Soc Neurosci 1988; 14:1182 (Abstract).
  10. Cunningham ET Jr, Simmons DM, Swanson LW, Sawchenko PE. Enkephalin-immunoreactivity and messenger RNA are expressed in a discrete projection from the nucleus of the solitary tract to the nucleus ambiguus in the rat. Absts Soc Neurosci 1989; 15:451 (Abstract).
  11. Cunningham ET Jr, Sawchenko PE. Brainstem projections from the nucleus of the solitary tract in the rat. Absts Soc Neurosci 1990; 16:1235 (Abstract).
  12. Labandeira-Garcia JL, Wictorin K, Cunningham ET Jr, Bjorklund A. Early host innervation of fetal striatal grafts implanted into the adult lesioned striatum. Eur Neurosci Assoc 1990; Stockholm (Abstract).
  13. Wada E, Cunningham ET Jr, Mitchell WM, Carter DB, Tracey DE, Battey JF, DeSouza EB. Identification of interleukin-1 mRNA in murine hippocampus. Absts Soc Neurosci 1990; 16:1213 (Abstract).
  14. Point SW, Jones B, Donner MW, Bryan RN, Cunningham ET Jr. Brain MRI of suspected neurogenic dysphagia. ASNR 1990; Los Angeles (Abstract).
  15. Cunningham ET Jr, Wada E, Carter DB, Tracey DE, Battey JF, De Souza EB. Localization of type I interleukin-1 receptor messenger RNA in the hypothalamic-pituitary-adrenal and gonadal axes. Absts Soc Neurosci 1991; 17:914 (Abstract).
  16. De Souza EB, Takao T, Cunningham ET Jr, Webster EL, Grigoriadis DE, Tracey DE. Interleukin-1 (IL-1) and corticotropin-releasing hormone (CRH) receptors in the brain-endocrine-immune axis: role in mediating stress response. Fifth Symposium on Catecholamines and Other Neurotransmitters in Stress 1991; Smolenice Castle, Czechoslovakia (Abstract).
  17. Sawchenko PE, Cunningham ET Jr, Bittencourt JC, Chan RKW. Aminergic and peptidergic pathways subserving the stress response. Fifth Symposium on Catecholamines and Other Neurotransmitters in Stress 1991; Czechoslovakia (Abstract).
  18. Cunningham ET Jr, Sawchenko PE. Medullary inputs to the fifth, seventh, and twelfth cranial nerve motor nuclei. Absts Soc Neurosci 1992; 18:1068 (Abstract).
  19. Cunningham ET Jr, Sanna PP, Liu S, Bloom FE, Margolis TP. Localization of tumor necrosis factor receptor messenger RNA in the central nervous system and pituitary gland of the mouse. Absts Soc Neurosci 1993; 18:225 (Abstract).
  20. Cunningham ET Jr, Sanna PP, Liu S, Bloom FE, Howes EL Jr, Margolis TP. In situ histochemical localization of type I IL-1 receptor messenger RNA in normal mouse eye. ARVO 1994; (Abstract).
  21. Cunningham ET Jr, Sanna PP, Bloom FE, Margolis TP. Localization of tumor necrosis factor receptor mRNA in normal and herpes simplex virus infected trigeminal ganglia in the mouse. Absts Soc Neurosci 1994; 20:952.
  22. Cunningham ET Jr, Margolis TP. Ocular sarcoidosis mimicking as serpiginous chorioretinopathy. Annual meeting of the Ocular Microbiology and Immunology Group 1995; Atlanta, Georgia (Abstract).
  23. Cunningham ET Jr, Short GA, Irvine AR, Duker JS, Margolis TP. AIDS-associated herpes simplex virus retinitis: Clinical description and use of a polymerase chain reaction-based assay as a diagnostic tool. ARVO 1996; (Abstract).
  24. Jones MR, Cunningham ET Jr. Bartonella henselae-associated acute multifocal retinitis in a patient with the acquired immune deficiency syndrome. Annual meeting of the Ocular Microbiology and Immunology Group 1996; Chicago, Il. (Abstract).
  25. Silverstein BE, Cunningham ET Jr, Margolis TP, Cevallos V, Wong IG. Microsporidial keratoconjunctivitis in a patient without HIV infection. Annual meeting of the Ocular Microbiology and Immunology Group 1996; Chicago, Il (Abstract).
  26. Sykes S, Cunningham ET Jr, Gritz D, Silverstein B, Nozik R, Whitcher J. Haemophilus influenza-associated necrotizing scleritis. Annual meeting of the Ocular Microbiology and Immunology Group 1996; Chicago, Il (Abstract).
  27. Chern KC, Cevallos V, Whitcher JP, Margolis TP, Cunningham ET Jr. Biotypes and serotypes of Haemophilus influenzae ocular isolates. Annual meeting of the Ocular Microbiology and Immunology Group 1997; San Francisco, CA. (Abstract).
  28. Zegans ME, Srinivasan M, McHugh T, Whitcher JP, Margolis TP, Cunningham ET Jr. Mooren’s ulcer in South India is not associated with hepatitis C infection. Annual meeting of the Ocular Microbiology and Immunology Group 1997; San Francisco, CA. (Abstract).
  29. Lowder CY, Cunningham ET Jr, Margolis TP, Gordon SM. Ocular tuberculosis and sarcoidosis mimicking serpiginous chorioretinopathy. American Uveitis Society 1997; San Francisco, CA (Abstract).
  30. Stechschulte SU, Cunningham ET Jr. Tuberculous neuroretinitis. Annual meeting of the Ocular Microbiology and Immunology Group 1997; San Francisco, CA. (Abstract).
  31. Geleziunas R, Lin X, Ferrell S, Cunningham ET Jr, Connelly MA, Marcu KB, Greene WC. HTLV-I Tax activation of NF-kB is mediated through the TNF-a inducible NIK and CHUK cellular kinases. Fourth West Coast Retrovirus Meeting 1997; Newport Beach, CA (Abstract).
  32. Chern KC, Nozik RA, Wong IG, Irvine AR, Cunningham ET Jr. Birdshot retinochoroidopathy: The Francis I. Proctor Foundation experience, 1977-1997. ARVO 1998; (Abstract).
  33. Zegans ME, Srinivasan M, Santhi CB, McHugh T, Whitcher JP, Margolis TP, Cunningham ET Jr. Mooren’s ulcer in South India is not associated with hepatitis C. ARVO 1998; (Abstract).
  34. Geleziunas R, Lin X, Ferrell S, Cunningham ET Jr, Connelly MA, Marcu KB, Greene WC. HTLV-I Tax induction of NF-kB is mediated through sequential activation of the NIK and IKKa cellular kinases. 5th Conference on Retroviruses and Opportunistic Infections 1998; Chicago, Illinois (Abstract).
  35. Xin L, Mu Y, Cunningham ET Jr, Marcu KB, Gelexiunas R, Greene WC. The role of NIK and IKKa complex formation in TNFa signaling. Keystone Symposium: Specificity in Signal Transduction 1998; Lake Tahoe, Nevada (Abstract).
  36. Mabon M, Smith J, Nozik RA, Wong IG, Cunningham ET Jr. (1998) Exudative retinal detachment in patients with uveitis. The Proctor Foundation experience, 1976-1996. American Uveitis Society 1998; (Abstract).
  37. Cubillan, LDP, Nozik RA, Wong IG, Cunningham ET Jr. The diagnostic importance of anterior granulomatous findings in patients with uveitis. American Uveitis Society 1998; (Abstract).
  38. Cunningham ET Jr, del Carmen J, Nozik RA, O’Connor GR, Wong LG, Neymark E. Uveitis in Children: The Proctor Foundation experience, 1977-1996. First Combined International Symposium on Ocular Immunology and Inflammation. Amsterdam, The Netherlands (Abstract).
  39. Hemady RK, Katz HR, Hirschbein MJ, O’Brien TP, Goyal RK, Acharya N, Cunningham ET Jr. Human immunodeficiency virus associated fungal keratitis: A multicenter report. American Academy of Ophthalmology 1998; New Orleans (Abstract).
  40. Cunningham ET Jr, Silverstein BE, Smith JH, Sykes SO, Jones MR, Schwartz D. Cystoid macular edema associated with cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome, 2nd International Conference on Ocular Infections 1998; Munich, Germany (Abstract).
  41. Cunningham ET Jr, Cubillan LDP, Nozik RA, Wong IG. The diagnostic importance of anterior granulomatous findings in patients with uveitis. 2nd International Conference on Ocular Infections 1998; Munich, Germany (Abstract).
  42. Cubillan LDP, Nozik RA, Wong IG, Cunningham ET Jr. Diagnostic importance of elevated intraocular pressure in patients with acute uveitis. American Uveitis Society 1998; (Abstract).
  43. Kuo I.C, Rao NA, Johnston R, Margolis TP, Nozik RA, Cunningham ET Jr. Subretinal fibrosis as a long-term complication of Vogt-Koyanagi-Harada syndrome. ARVO 1999; (Abstract).
  44. Wade NK, Levi L, Jones M, Batra N, Cunningham ET Jr. Peripapillary serous retinal detachment as an early sign of systemic Bartonella henselae infection. American Uveitis Society 1999; (Abstract).
  45. Cubillan LDP, Nozik RA, Wong IG, Cunningham ET Jr. The diagnostic importance of elevated intraocular pressure in patients with acute uveitis. ARVO 1999; (Abstract).
  46. Jacobson MA, Stanley S, Holtzer C, Margolis T, Cunningham ET Jr. Natural history and outcome of new AIDS-related CMV retinitis cases diagnosed in the era of highly active antiretroviral therapy (HAART). Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco 1999; (Abstract).
  47. Kuo IC, Chen P, Frederick DR, Pepin S, Emery H, Cunningham ET Jr. Ocular manifestations of neonatal onset multisystem inflammatory disease. Annual meeting of the Ocular Microbiology and Immunology Group 1999; Orlando, FL. (Abstract).
  48. Cunningham ET Jr, Chiu C, Cubillan DP. Prevalence and patterns of presumed syphilitic uveitis. Fifth International Symposium on Uveitis 2001; Buenos Aires, Argentina. (Abstract).
  49. Chang MS, Lee SS, Cunningham ET Jr. Focal retinal phlebitis as a presenting sign of systemic Bartonella henselae infection. Annual meeting of the Ocular Microbiology and Immunology Group, 2000; Dallas, TX. (Abstract).
  50. Tham VM-B, Cunningham ET Jr. Anterior optic neuropathy in a patient with HLA-B27 associated recurrent uveitis and ankylosing spondylitis. Annual meeting of the Ocular Microbiology and Immunology Group 2000; Dallas, TX. (Abstract).
  51. Tham VM-B, Chern KC, Hall AJH, Cunningham ET Jr. Birdshot retinochoroidopathy: Prevalence, clinical characteristics, and causes of vision loss. The Francis I. Proctor Foundation Experience. The Third International Symposium of Ophthalmology on “The Challenges and Controversies of Ophthalmology & Visual Sciences in the New Millennium 2000; Hong Kong, China. (Abstract).
  52. Alrawi AM, Chern KC, Cevallos V, Lietman T, Whitcher JP, Margolis TP, Cunningham ET Jr. Biotypes and serotypes of Haemophilus influenzae ocular isolates. ARVO 2001; (Abstract 1368; Poster).
  53. Siverio CD, Cubillan LDP, Cunningham ET Jr. Smoking as a risk factor for vision loss due to cystoid macular edema in patients with idiopathic intermediate uveitis. IOVS 2001; 42:S708.
  54. Shein J, Wu S, Shukla D, Yannuzzi LA, Cunningham ET Jr. Macular infarction as a presenting sign in systemic lupus erythematosus. American Uveitis Society, ARVO 2004.
  55. Jager RD, Aiello LP, Patel SC, Cunningham ET Jr. Risks of intravitreous injection: An evidence-based review. ASRS San Diego 2004.
  56. Cunningham ET Jr for the Macugen Study Group. The pharmacokinetics and immunogenicity of pegaptanib sodium (MacugenTM) following intravitreous injection in patients with neovascular age-related macular degeneration. The Retina Society, Baltimore 2004.
  57. Flynn HW Jr for the Intravitreous Injection Guidelines Panel. Evolving practice guidelines for intravitreous injections. The 28th Annual Macula Society Meeting. Key Biscayne, Florida, 2005.
  58. Cunningham ET Jr, Jager RD, Aiello LP, Patel SC. Risks of Intravitreous Injection: A Systematic Review. The 28th Annual Macula Society Meeting. Key Biscayne, Florida, 2005.
  59. Acharya N, Srinivasan M, Zegans M, Magone T, Lietman T, Cunningham ET Jr, Whitcher J.P. Characteristics of Mooren’s ulcer in surgical vs non-surgical patients. ARVO 2005, (Abstract 5008-B211).
  60. Reddy S, Cubillan LDP, Hovakimyan A, Cunningham ET Jr. Inflammatory ocular hypertension syndrome (IOHS) in patients with uveitis. ARVO 2006, Abstract # 1273-B209.
  61. Zelefsky JR, Srinivasan M, Lietman T, Whitcher JP, Wang K, Buyse M, Cunningham ET Jr. Hookworm infestation as a risk factor for Mooren’s ulcer in South India. ARVO 2006, Abstract # 4383-B28.
  62. Sanchez JG, Arevalo JF, Cunningham ET Jr. Tuberculous uveitis: A global perspective. World Ophthalmology Congress 2006. Sao Paulo, Brazil.
  63. Cunningham ET Jr. Guidelines for safe administration of intravitreous injection: An expert panel consensus. World Ophthalmology Congress 2006. Sao Paulo, Brazil.
  64. Reddy S, Cubillan LDP, Hovakimyan A, Cunningham ET Jr. Causes of inflammatory ocular hypertension syndrome (IOHS). IUSG Meeting. World Ophthalmology Congress 2006. Sao Paulo, Brazil.
  65. Cunningham ET, Jr., Javitt JC, Zlateva GP, Zhou S, Shah SN. Comparison of comorbid conditions between wet AMD patients and a control cohort in the Medicare population. Presented at: the 24th Annual Meeting of the ASRS & 6th Annual Meeting of the EVRS, 2006, Cannes, France.
  66. Cunningham ET, Jr. Update on the Risks Associated with Intravitreous (IVT) Injection and Guidelines for Safe Administration. Presented at: the 24th Annual Meeting of the ASRS & 6th Annual Meeting of the EVRS, 2006, Cannes, France.
  67. Elledge JA, Webster MKW, Altaweel, M, Goldbaum M, Cunningham ET Jr, Davis MD, Katz, B. Alternative measures of fluorescein leakage in the angiographic evaluation of eyes with AMD: Experience of the Wisconsin Reading Center and the V.I.S.I.O.N. trials. ARVO 2006.
  68. Cunningham ET, Jr. Risks associated with intravitreous injection. The 6th International Symposium of Ophthalmology. Hong Kong (ISOKH), 2006.
  69. Cunningham ET, Jr. Safety and efficacy of Macugen in treating neovascular AMD. The 6th International Symposium of Ophthalmology. Hong Kong (ISOKH), 2006.
  70. Roe R, Bui A, Jumper JM, Fu AD, McDonald HR, Johnson RN, Cunningham ET Jr. An Atypical presentation of VKH disease. Sociedad Panamericana de Enfermedades Inflamatorias Oculares (SPEIO) Special Clinical Case Presentations. PanAmerican Association of Ophthalmology (PAAO). Cancun, Mexico, 2007.
  71. Wender JD, Fu AD, Jumper JM, McDonald HR, Johnson RN, Cunningham ET Jr. False negative antibody-based HLA-A29 typing in patients with birdshot chorioretinopathy. Sociedad Panamericana de Enfermedades Inflamatorias Oculares (SPEIO) Special Clinical Case Presentations. PanAmerican Association of Ophthalmology (PAAO). Cancun, Mexico, 2007.
  72. Goff MJ, Wender JD, Bui AT, Jumper JM, Cuningham ET Jr, Fu AD, Johnson RN, McDonald HR. The outcomes of primary pneumatic retinopexy performed by vitreoretinal fellows. American Academy of Ophthalmology, New Orleans, 2007. Poster PO239.
  73. Cunningham ET Jr, Wender JD, Fu AD, Jumper JM, McDonald HR, Johnson RN. False negative antibody-based HLA-A29 typing in patients with birdshot chorioretinopathy. 9th International Ocular Inflammation Society (IOIS) Congress. Paris, France, 2007.
  74. Wender JD, Fu AD, Jumper JM, McDonald HR, Johnson RN, Cunningham ET Jr. Birdshot…..or not? Atlantic Coast Retina Club. Philadelphia, USA 2008.
  75. Shukla D, Behera UC, Rathinam SR, Cunningham ET Jr. Acute posterior multifocal placoid pigment epitheliopathy associated with serous retinal detachment: clinical characteristics, angiographic features and management. Western Retina Study Group. San Francisco, CA 2008.
  76. Jumper JM, Pomerleau D, Mcdonald HR, Johnson RN, Fu AD, Cunningham ET Jr. Macular fibrosis in Coats’ disease. Retina Society, Phoenix, AZ 2008.
  77. Wong RW, Roe RH, Rathinam SR, McDonald HR, Jumper JM, Cunningham ET Jr. Delayed fellow eye involvement in Vogt-Koyanagi-Harada disease. American Uveitis Society Meeting, ARVO 2008.
  78. Nair UK, Bui A, Roe R, Fu AD, Jumper JM, Johnson RN, McDonald HR, Cunningham ET Jr. Blood pressure measurements following intravitreal ranibizumab. ARVO, 2008 (4577-A123).
  79. Martin TD, Rathinam SR, Cunningham ET Jr. Pediatric VKH - A Retrospective Clinic Based Cohort Study from South India. Sociedad Panamericana de Enfermedades Inflamatorias Oculares. AAO, Atlanta, GA (Abstract, Presentation).
  80. Martin TD, Rathinam SR, Cunningham ET Jr. Prevalence, Clinical Characteristics, and Causes of Vision Loss in Children with Vogt-Koyanagi-Harada Disease in South India. American Academy of Pediatric Ophthalmology and Strabismus (AAPOS) 35th Annual Meeting, April 17-21, 2009, San Francisco, CA.
  81. Cunningham ET Jr. Characteristic findings in patients with syphilitic retinitis. Western Retina Study Club, March 13-14, San Diego, CA.
  82. Cunningham ET Jr, Feiner L, Chung CY, Rundle AC, Tuomi L. Incidence of retinal pigment epithelial (RPE) tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration. Retina Congress 2009 New York, Sept 30-Oct 4, 2009. Poster
  83. Jumper JM, Doshi R, Spencer WH, McDonald HR, Johnson RN, Cunningham ET Jr, Fu AD. Persistent fetal vasculature masquerading as ocular cysticercosis. Retina Congress 2009 New York, Sept 30-Oct 4, 2009, Medical Retina Case Conference. Presentation #5071
  84. Cunningham ET Jr, London NJS, Hovakimyan A. Causes of vision loss in a large cohort with ocular toxoplasmosis. 33rd Annual Macula Society Meeting. Tucson, AZ. 2010.
  85. London NJS, Dhananjay S, Heiden D, Rathinam SR, Arevalo JF, Cunningham ET Jr. HIV/AIDS in the developing world. International Ophthalmology Clinics 2010; 50(2):201-218.
  86. Nair U, Cunningham ET Jr. Uveitis: Diagnostic and Ancillary Approach. In Duane’s Clinical Ophthalmology, Volume 4, Ch 37, Diseases of the Uvea 2010; Howard Tessler (Section Editor), Tasman W, Jaeger EA (Series Editors). Lippincott,Williams & Wilkins, Philadelphia 2011. Available at www.duanesophthalmology.com or Duane’s Ophthalmology on DVD.ROM 2011 ed.
  87. London NJS, Cunningham ET Jr. Ocular Manifestations of HIV/AIDS. In: Duane’s Foundations of Clinical Ophthalmology, Volume 3, CH 36, Ocular Pharmacology 2010; Steven Teich (Section Editor), Tasman W, Jaeger EA (Series Editors). Lippincott, Williams & Wilkins, Philadelphia 2011. Available at www.duanesophthalmology.com or Duane’s Ophthalmology on DVD.ROM 2011 ed.
  88. Fu AJ, Jumper JM, McDonald RM, Johnson RN, Ai E, Cunningham ET Jr. In: Duanes Ophthalmology. Acquired Macular Disease, Chapter 23. Lippincott Williams & Wilkins, Philadelphia, 2010, In press.
  89. London NJS, Cunningham ET Jr. Uveitis in immunocompromised patients. In: Intraocular Inflammation. Zierhut M, Ohno S, Orefice F, Pavesio C, Rao N (Eds). Springer-Verlag, London. 2010, in press.
  90. London NJS, Cunningham ET Jr. HIV. In: Intraocular Inflammation. Zierhut M, Ohno S, Orefice F, Pavesio C, Rao N (Eds). Springer-Verlag, London. 2010, in press.
  91. London NJS, Cunningham ET Jr. Pneumocystosis. In: Intraocular Inflammation. Zierhut M, Ohno S, Orefice F, Pavesio C, Rao N (Eds). Springer-Verlag, London. 2010, in press.
  92. London NJS, Cunningham ET Jr. Neuroretinitis. In: Intraocular Inflammation. Zierhut M, Ohno S, Orefice F, Pavesio C, Rao N (Eds). Springer-Verlag, London. 2010, in press.
  93. Wender JD, Cunningham ET Jr. Borreliosis. In: Intraocular Inflammation. Zierhut M, Ohno S, Orefice F, Pavesio C, Rao N (Eds). Springer-Verlag, London. 2009, in press.
  94. Nair U, Moorthy RS, Cunningham ET Jr. Histoplasmosis. In: Intraocular Inflammation. Zierhut M, Ohno S, Orefice F, Pavesio C, Rao N (Eds). Springer-Verlag, London. 2010, in press.
  95. Roe RH, Jumper JM, Fu AD, Johnson RN, McDonald HR, Cunningham ET Jr. Bartonella. In: Intraocular Inflammation. Zierhut M, Ohno S, Orefice F, Pavesio C, Rao N (Eds). Springer-Verlag, London. 2010, in press.
  96. Zelefsky JD, Cunningham ET Jr. Mooren’s ulcer. In: Uveitis – Color Atlas and Synopsis of Clinical Ophthalmology – Wills Eye Institute, Second Edition. Garg S (Editor); Bodaghi B, Nussenblatt R, Rathinam SR, Sen HN (Section Editors). Lippincott Williams & Wilkins, Philadelphia, 2011, 28-30.
  97. Wong R, Rathinam SR, Cunningham ET Jr. Systemic lupus erythematosus. In: Uveitis – Color Atlas and Synopsis of Clinical Ophthalmology – Wills Eye Institute, Second Edition. Garg S (Editor); Bodaghi B, Nussenblatt R, Rathinam SR, Sen HN (Section Editors). Lippincott Williams & Wilkins, Philadelphia, 2011, 91-94.
  98. Doshi R, Rathinam SR, Cunningham ET Jr. Sympathetic ophthalmia. In: Uveitis – Color Atlas and Synopsis of Clinical Ophthalmology – Wills Eye Institute, Second Edition. Garg S (Editor); Bodaghi B, Nussenblatt R, Rathinam SR, Sen HN (Section Editors). Lippincott Williams & Wilkins, Philadelphia, 2011, 72-75.
  99. Arevalo JF, Belfort R Jr, Espinoza JV, Muccioli C, Cunningham ET Jr. Retinal and choroidal manifestations of toxoplasmosis. In: Retinal and Choroidal Manifestations of Selected Systemic Diseases. Arevalo JF, Editor. Springer, New York, 2013. Chapter 6, pp79-104.
  100. Arevalo JF, Garcia RA, Tata LS, de Amorim Garcia A, Orefice F, Curi A, Cunningham ET Jr. Diffuse unilateral subacute neuroretinitis (DUSN). In: Retinal and Choroidal Manifestations of Selected Systemic Diseases. Arevalo JF, Editor. Springer, New York, 2013. Chapter 2, pp23-35.
  101. Arevalo JF, Garcia RA, London NJS, Cunningham ET Jr, Belfort R Jr, Freeman WR. Retinal and choroidal manifestations of AIDS. In: Retinal and Choroidal Manifestations of Selected Systemic Diseases. Arevalo JF, Editor. Springer, New York, 2013. Chapter 1, pp1-22.
  102. Cunningham ET Jr. What diseases should I consider in a patient with neuroretinitis? In: Curbside Consultation in Uveitis. Foster CS (Editor). Hinkle DM and Opremcak EM (Associate Editors). Slack Book Incorporated. Thorofare, NJ. 2012, Chapter 27, 103-106.
  103. Salz D, Prenner J, Cunningham ET Jr. Local complications of IV anti-VEGF therapy. Review of Ophthalmology. November, 2010: 66-75.
  104. Chappell MC, Jumper JM, McDonald HR, Cunningham ET Jr. Spotting Bartonella-associated uveitis. Review of Ophthalmology. March, 2011: 112-117.
  105. Chan P, Iranmanesh R, Cunningham ET Jr. The case of the blurry-eyed graphic designer. EyeNet. April, 2011:47-48.
  106. Gess A, Wender J, Jumper JM, Cunningham ET Jr. The red eye from Rio. EyeNet. May, 2011:1-2
  107. Cunningham ET Jr, Kestelyn, P, Pavesio CE. Ocular manifestations of HIV/AIDS in children. In: Hoyt C and Taylor D Eds; Pediatric Ophthalmology and Strabismus, Fourth Edition; Elsevier, London, UK. 2011, In press.
  108. Zelefsky JR, Cunningham ET Jr. The surgical management of uveitic glaucoma. In: Eliot D, Rao PK (eds). Surgical Management of Intraocular Inflammation and Infection. London: JP Medical Ltd, 2013. Chapter 2, 9-13.
  109. Cunningham ET Jr, Augsburger JJ, Correa ZM, Pavesio C. Uveal tract and sclera. In: Vaughan & Asbury's General Ophthalmology. 2011 18th Edition. Riordan-Eva P, Cunningham ET Jr, eds. Appleton & Lange, Stamford, Connecticut, Chapter 7, 145-173.
  110. Fu AD, Ai E, McDonald HR, Johnson RN, Jumper JM, Cunningham ET Jr, Lujan B. Hereditary macular dystrophies. In: Duane's Clinical Ophthalmology 2012, In press.
  111. Cunningham ET Jr, “Uveitis,” in The Merck Manual Home Health Handbook, John Wiley & Sons, Inc., last published 2009, updated continuously online at www.merckmanuals.com/home.
  112. Cunningham ET Jr, “Uveitis,” in The Merck Manual of Diagnosis and Therapy, Merck Sharp & Dohme Corp., last published 2011, changed to “Uveitis and Related Disorders” and updated continuously online at www.merckmanuals.com/professsional
  113. Wong RW, Cunningham ET Jr. Posterior segment findings in SLE. Review of Ophthalmology 2013, January, 41-45.
Return to Top